[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 105
1. Rosbottom KJ, Michie B, Boyce S: Metastasis of recurrent colonic adenocarcinoma to the mouth. BMJ Case Rep; 2009;2009

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastasis of recurrent colonic adenocarcinoma to the mouth.
  • Colorectal adenocarcinoma is a common cancer; however, reports of metastases to the oral region are uncommon.
  • Oral metastases often indicate disseminated disease, the prognosis is poor and management is often palliative.
  • We report the case of a 73-year-old man with recurrent metastatic disease who presented 2 years following his initial surgery for a left-sided colonic adenocarcinoma with a painful oral tumour.
  • Biopsy confirmed adenocarcinoma with similar features to the original colonic tumour; the patient went on to have palliation of his symptoms with radiotherapy.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Oral Surg. 1975 Jan;33(1):53-6 [1053651.001]
  • [Cites] Br J Oral Maxillofac Surg. 2003 Feb;41(1):3-6 [12576032.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1965 Sep;20:350-62 [14342927.001]
  • [Cites] Eur J Cancer B Oral Oncol. 1995 Nov;31B(6):355-60 [8746264.001]
  • [Cites] Ann Surg. 1940 Jul;112(1):138-49 [17857618.001]
  • [Cites] Oral Oncol. 2008 Aug;44(8):743-52 [18061527.001]
  • [Cites] J Oral Pathol. 1987 Aug;16(7):362-7 [3117991.001]
  • [Cites] J Natl Cancer Inst. 2004 Oct 6;96(19):1420-5 [15467030.001]
  • (PMID = 21754956.001).
  • [ISSN] 1757-790X
  • [Journal-full-title] BMJ case reports
  • [ISO-abbreviation] BMJ Case Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC3028428
  •  go-up   go-down


2. Whitt JC, Schafer DR, Callihan MD: Multiple malignant salivary gland neoplasms: mucoepidermoid carcinoma of palate and adenoid cystic carcinoma of floor of mouth. Head Neck Pathol; 2008 Mar;2(1):41-8
MedlinePlus Health Information. consumer health - Salivary Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Multiple malignant salivary gland neoplasms: mucoepidermoid carcinoma of palate and adenoid cystic carcinoma of floor of mouth.
  • We report a case of an adult male who presented with a mucoepidermoid carcinoma involving the minor salivary glands of the palate at age 57 years, followed by an adenoid cystic carcinoma of the floor of mouth at age 63 years.
  • Bilateral acinic cell adenocarcinoma was the most frequent combination of multiple salivary gland malignancy, accounting for 14 cases (10 synchronous and four metachronous).
  • Polymorphous low-grade adenocarcinoma accounted for three of the four cases of multiple malignant tumors involving minor salivary glands.
  • [MeSH-major] Carcinoma, Adenoid Cystic / pathology. Carcinoma, Mucoepidermoid / pathology. Mouth Neoplasms / pathology. Neoplasms, Multiple Primary / pathology. Palatal Neoplasms / pathology. Salivary Gland Neoplasms / pathology. Salivary Glands, Minor / pathology

  • Genetic Alliance. consumer health - Adenoid Cystic Carcinoma.
  • Genetic Alliance. consumer health - Mucoepidermoid carcinoma.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Oral Surg Oral Med Oral Pathol. 1988 Aug;66(2):179-83 [3050706.001]
  • [Cites] Head Neck. 2005 Sep;27(9):825-8 [15920750.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Apr;91(4):455-61 [11312463.001]
  • [Cites] Ann Surg. 1969 Nov;170(5):866-9 [5347563.001]
  • [Cites] Surg Gynecol Obstet. 1974 Jan;138(1):65-8 [4809004.001]
  • [Cites] Sem Hop. 1973 Jun 14;49(28):2031-3 [4359568.001]
  • [Cites] Am J Clin Pathol. 1974 Feb;61(2):270-4 [4811743.001]
  • [Cites] Arch Surg. 1975 Jan;110(1):64-8 [1090282.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1976 Jun;41(6):764-71 [179038.001]
  • [Cites] Tumori. 1975 Jan-Feb;61(1):39-43 [179172.001]
  • [Cites] Cancer. 1976 Dec;38(6):2462-8 [1000476.001]
  • [Cites] Ann Surg. 1976 Oct;184(4):500-6 [1015893.001]
  • [Cites] Ann Intern Med. 1977 Aug;87(2):160-4 [889197.001]
  • [Cites] Laryngol Rhinol Otol (Stuttg). 1977 Nov;56(11):907-11 [201812.001]
  • [Cites] Cancer. 1978 Mar;41(3):924-35 [638978.001]
  • [Cites] Laryngoscope. 1978 Dec;88(12):1935-41 [732494.001]
  • [Cites] ORL J Otorhinolaryngol Relat Spec. 1978;40(2):120-6 [570688.001]
  • [Cites] Plast Reconstr Surg. 1980 May;65(5):676-8 [6245420.001]
  • [Cites] Am J Pathol. 1982 Oct;109(1):129-32 [6289671.001]
  • [Cites] Cancer. 1983 Jun 15;51(12):2159-63 [6850504.001]
  • [Cites] J Laryngol Otol. 1985 Nov;99(11):1183-93 [4056607.001]
  • [Cites] Hum Pathol. 1986 Sep;17(9):914-23 [3759075.001]
  • [Cites] J Natl Cancer Inst. 1988 Aug 17;80(12):943-9 [3398070.001]
  • [Cites] Cancer. 1989 Mar 15;63(6):1219-24 [2917323.001]
  • [Cites] Br J Oral Maxillofac Surg. 1989 Jun;27(3):192-7 [2663053.001]
  • [Cites] Ann Pathol. 1989;9(5):351-4 [2558664.001]
  • [Cites] J Laryngol Otol. 1991 Sep;105(9):796-8 [1919360.001]
  • [Cites] Br J Surg. 1992 Sep;79(9):928-30 [1422760.001]
  • [Cites] Community Dent Oral Epidemiol. 1992 Oct;20(5):284-7 [1424549.001]
  • [Cites] Am J Surg. 1992 Dec;164(6):646-7 [1334381.001]
  • [Cites] J Oral Pathol Med. 1993 Sep;22(8):348-53 [8283400.001]
  • [Cites] J Laryngol Otol. 1994 Sep;108(9):798-800 [7964150.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995 Jul;80(1):71-7 [7552866.001]
  • [Cites] Eur J Cancer B Oral Oncol. 1996 Jan;32B(1):3-7 [8729611.001]
  • [Cites] Oral Oncol. 1997 Jul;33(4):284-7 [9307720.001]
  • [Cites] Virchows Arch. 1999 Apr;434(4):361-5 [10335948.001]
  • [Cites] J Laryngol Otol. 2003 May;117(5):419-21 [12803799.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1966 Sep;75(3):780-92 [5917646.001]
  • [Cites] Arch Pathol Lab Med. 1999 Nov;123(11):1118-20 [10539921.001]
  • [Cites] Am J Surg. 1969 Nov;118(5):787-9 [4310431.001]
  • [Cites] AMA Arch Pathol. 1953 Apr;55(4):328-46 [13030050.001]
  • [Cites] Plast Reconstr Surg Transplant Bull. 1959 Jan;23(1):55-63 [13633480.001]
  • [Cites] J Laryngol Otol. 1961 Jul;75:699-702 [13722582.001]
  • [Cites] Acta Otolaryngol Suppl. 1964;188:SUPPL 191:1-99 [14156485.001]
  • [Cites] Cancer. 1966 Sep;19(9):1308-10 [5919065.001]
  • (PMID = 20614341.001).
  • [ISSN] 1936-0568
  • [Journal-full-title] Head and neck pathology
  • [ISO-abbreviation] Head Neck Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2807610
  • [Keywords] NOTNLM ; Metachronous neoplasms / Multiple malignant salivary gland neoplasms / Salivary gland neoplasms / Salivary gland tumors / Synchronous neoplasms
  •  go-up   go-down


3. Sánchez-Jiménez J, Acebal-Blanco F, Arévalo-Arévalo RE, Molina-Martínez M: Metastatic tumours in upper maxillary bone of esophageal adenocarcinoma. A case report. Med Oral Patol Oral Cir Bucal; 2005 May-Jul;10(3):252-7
MedlinePlus Health Information. consumer health - Esophageal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastatic tumours in upper maxillary bone of esophageal adenocarcinoma. A case report.
  • Metastases in the oral cavity are rare lesions which represent approximately 1% of all malignant neoplasms in the oral cavity.
  • Oral metastases are located in the mandible 80-90% on average, the maxilla location being rarer.
  • Metastases in mouth soft tissue are also rare, and within these it is on the gums where they more frequently occur.
  • Primary tumours which metastasize to mouth are most commonly: lung, breast and kidney.
  • Oral cavity metastases appear as a result of distant disease spreading and show wrong prognosis, with short survival.
  • Here we present a clinical case of a patient diagnosed with esophagus adenocarcinoma which presented metastasis in upper-left maxillary bone.
  • [MeSH-major] Adenocarcinoma / secondary. Esophageal Neoplasms / pathology. Maxillary Neoplasms / secondary. Maxillary Sinus Neoplasms / secondary

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15876970.001).
  • [ISSN] 1698-6946
  • [Journal-full-title] Medicina oral, patología oral y cirugía bucal
  • [ISO-abbreviation] Med Oral Patol Oral Cir Bucal
  • [Language] eng; spa
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


Advertisement
4. Yamate J, Yamamoto E, Nabe M, Kuwamura M, Fujita D, Sasai H: Spontaneous adenocarcinoma immunoreactive to cyclooxygenase-2 and transforming growth factor-beta1 in the buccal salivary gland of a Richardson's ground squirrel (Spermophilus richardsonii). Exp Anim; 2007 Oct;56(5):379-84
MedlinePlus Health Information. consumer health - Salivary Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Spontaneous adenocarcinoma immunoreactive to cyclooxygenase-2 and transforming growth factor-beta1 in the buccal salivary gland of a Richardson's ground squirrel (Spermophilus richardsonii).
  • This tumor was diagnosed as an adenocarcinoma arising from the buccal gland, the first case reported in the ground squirrel.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18075199.001).
  • [ISSN] 1341-1357
  • [Journal-full-title] Experimental animals
  • [ISO-abbreviation] Exp. Anim.
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Transforming Growth Factor beta1; EC 1.14.99.1 / Cyclooxygenase 2
  •  go-up   go-down


5. Check JH, Dix E, Sansoucie L, Check D: Mifepristone may halt progression of extensively metastatic human adenocarcinoma of the colon - case report. Anticancer Res; 2009 May;29(5):1611-3
Hazardous Substances Data Bank. MIFEPRISTONE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mifepristone may halt progression of extensively metastatic human adenocarcinoma of the colon - case report.
  • MATERIALS AND METHODS: Mifepristone 200 mg per day by mouth was given to two patients with stage 4 colon cancer with extensive metastases.
  • [MeSH-major] Adenocarcinoma / drug therapy. Colonic Neoplasms / drug therapy. Mifepristone / therapeutic use

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19443374.001).
  • [ISSN] 0250-7005
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 320T6RNW1F / Mifepristone
  •  go-up   go-down


6. Attia S, Kolesar J, Mahoney MR, Pitot HC, Laheru D, Heun J, Huang W, Eickhoff J, Erlichman C, Holen KD: A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas. Invest New Drugs; 2008 Aug;26(4):369-79
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas.

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18278438.001).
  • [ISSN] 0167-6997
  • [Journal-full-title] Investigational new drugs
  • [ISO-abbreviation] Invest New Drugs
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / P30 CA006973; United States / NCI NIH HHS / CM / N01 CM062205; United States / NCI NIH HHS / CM / N01 CM-62205; United States / PHS HHS / / 1ULIRR025011; United States / NCRR NIH HHS / RR / UL1 RR025011; United States / NCI NIH HHS / CA / T32 CA009614; United States / PHS HHS / / 24XS090
  • [Publication-type] Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Pyridines; 0 / Thiosemicarbazones; 0W860991D6 / Deoxycytidine; 143621-35-6 / 3-aminopyridine-2-carboxaldehyde thiosemicarbazone; B76N6SBZ8R / gemcitabine; EC 1.17.4.- / ribonucleotide reductase M2; EC 1.17.4.1 / Ribonucleoside Diphosphate Reductase
  • [Other-IDs] NLM/ NIHMS692508; NLM/ PMC4461052
  •  go-up   go-down


7. Kariya S, Kosaka M, Orita Y, Akagi H, Nishizaki K: Adenocarcinoma ex pleomorphic adenoma of the head and neck: Report of five cases. Auris Nasus Larynx; 2006 Mar;33(1):43-6
Hazardous Substances Data Bank. FLUOROURACIL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenocarcinoma ex pleomorphic adenoma of the head and neck: Report of five cases.
  • OBJECTIVE: Adenocarcinoma ex pleomorphic adenoma is a rare tumor, and thus the management of the tumor has not been established.
  • RESULTS: We present five cases of adenocarcinoma ex pleomorphic adenoma of the head and neck, including a rare case with nasopharyngeal adenocarcinoma ex pleomorphic adenoma.
  • There was no response to chemotherapy with nedaplatin and 5-FU, but the nasopharyngeal adenocarcinoma ex pleomorphic adenoma showed a remarkable regression after the administration of docetaxel.
  • CONCLUSION: The combination therapy that includes docetaxel may be a promising treatment for adenocarcinoma ex pleomorphic adenoma of the head and neck.
  • [MeSH-major] Adenoma, Pleomorphic / pathology. Mouth Neoplasms / pathology. Nasopharyngeal Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • Hazardous Substances Data Bank. DOCETAXEL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16168590.001).
  • [ISSN] 0385-8146
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Organoplatinum Compounds; 0 / Taxoids; 15H5577CQD / docetaxel; 8UQ3W6JXAN / nedaplatin; U3P01618RT / Fluorouracil
  •  go-up   go-down


8. Hattori T, Wang PL: Calcium antagonists cause dry mouth by inhibiting resting saliva secretion. Life Sci; 2007 Aug 2;81(8):683-90
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Calcium antagonists cause dry mouth by inhibiting resting saliva secretion.
  • Ca2+ antagonists cause dry mouth by inhibiting saliva secretion.
  • The present study was undertaken to elucidate the mechanism by which Ca2+ antagonists cause dry mouth.
  • We therefore conclude that non-selective cation and voltage-dependent Ca2+ channels are involved in resting salivation and that Ca2+ antagonists depress H2O secretion by blocking the Ca2+ channels and thereby cause dry mouth.
  • [MeSH-minor] 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester / pharmacology. Adenocarcinoma / metabolism. Calcium / metabolism. Calcium Channel Agonists / pharmacology. Carbachol / pharmacology. Cell Line, Tumor. Depression, Chemical. Endothelin-1 / pharmacology. Humans. Imidazoles / pharmacology. Isoenzymes / metabolism. Microscopy, Fluorescence. Muscarinic Agonists / pharmacology. Norepinephrine / pharmacology. Phospholipase C beta. Submandibular Gland Neoplasms / metabolism. Type C Phospholipases / metabolism. Vasoconstrictor Agents / pharmacology

  • MedlinePlus Health Information. consumer health - Dry Mouth.
  • Hazardous Substances Data Bank. Norepinephrine .
  • Hazardous Substances Data Bank. CARBACHOL CHLORIDE .
  • Hazardous Substances Data Bank. CALCIUM, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17688889.001).
  • [ISSN] 0024-3205
  • [Journal-full-title] Life sciences
  • [ISO-abbreviation] Life Sci.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Calcium Channel Agonists; 0 / Calcium Channel Blockers; 0 / Endothelin-1; 0 / Imidazoles; 0 / Isoenzymes; 0 / Muscarinic Agonists; 0 / Vasoconstrictor Agents; 130495-35-1 / 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole; 71145-03-4 / 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; 8Y164V895Y / Carbachol; EC 3.1.4.- / Type C Phospholipases; EC 3.1.4.11 / Phospholipase C beta; SY7Q814VUP / Calcium; X4W3ENH1CV / Norepinephrine
  •  go-up   go-down


9. Uji M, Matsushita H, Watanabe T, Suzumura T: [A case of primary Sjögren's syndrome complicated with lung adenocarcinoma]. Nihon Kokyuki Gakkai Zasshi; 2007 May;45(5):409-12
MedlinePlus Health Information. consumer health - Sjogren's Syndrome.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of primary Sjögren's syndrome complicated with lung adenocarcinoma].
  • The serum value of carcinoembryonic antigen was highly elevated, so we made a presumed diagnosis of primary non-small lung cancer.
  • She also complained of dry eyes and mouth.
  • The elevated values of serum antibodies against SS-A and SS-B and further examinations resulted in a definitive diagnosis of primary Sjögren's syndrome.
  • Autopsy revealed that the mass shadow was a primary lung adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / complications. Lung Neoplasms / complications. Sjogren's Syndrome / complications

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17554985.001).
  • [ISSN] 1343-3490
  • [Journal-full-title] Nihon Kokyūki Gakkai zasshi = the journal of the Japanese Respiratory Society
  • [ISO-abbreviation] Nihon Kokyuki Gakkai Zasshi
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


10. Geha H, François A, Boland F, Drikes S, Peron J: Polymorphous low-grade adenocarcinoma: a review regarding an unusual presentation as infected odontogenic cyst. J Plast Reconstr Aesthet Surg; 2009 Jun;62(6):742-6
MedlinePlus Health Information. consumer health - Oral Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Polymorphous low-grade adenocarcinoma: a review regarding an unusual presentation as infected odontogenic cyst.
  • The World Health Organisation (WHO) classified polymorphous low-grade adenocarcinoma (PLGA) in 1990 as a low-grade malignancy; ICD-O 8525/3 being the assigned international code.
  • [MeSH-major] Adenocarcinoma / complications. Mouth Neoplasms / complications. Odontogenic Cysts / etiology

  • Genetic Alliance. consumer health - Polymorphous low-grade adenocarcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19109086.001).
  • [ISSN] 1878-0539
  • [Journal-full-title] Journal of plastic, reconstructive & aesthetic surgery : JPRAS
  • [ISO-abbreviation] J Plast Reconstr Aesthet Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Netherlands
  • [Number-of-references] 53
  •  go-up   go-down


11. Parashar P, Baron E, Papadimitriou JC, Ord RA, Nikitakis NG: Basal cell adenocarcinoma of the oral minor salivary glands: review of the literature and presentation of two cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Jan;103(1):77-84
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Basal cell adenocarcinoma of the oral minor salivary glands: review of the literature and presentation of two cases.
  • Basal cell adenocarcinoma (BCA) is an unusual salivary gland malignancy that very rarely affects the minor glands.
  • A comprehensive literature review revealed only 21 previously reported cases of BCA of oral minor salivary glands.
  • [MeSH-major] Adenocarcinoma / pathology. Salivary Gland Neoplasms / pathology. Salivary Glands, Minor / pathology
  • [MeSH-minor] Adult. Aged. Female. Humans. Mouth Mucosa / pathology. Mouth Mucosa / surgery. Palate / pathology. Palate / surgery

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17178498.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 35
  •  go-up   go-down


12. Petersen SK, Bjørndal K, Krogdahl A, Godballe C: [Basal cell adenocarcinoma of the sublingual gland]. Ugeskr Laeger; 2010 Feb 15;172(7):551-2
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Basal cell adenocarcinoma of the sublingual gland].
  • The cause of a swelling in the floor of the mouth will in most cases be benign.
  • [MeSH-major] Adenocarcinoma / pathology. Sublingual Gland Neoplasms / pathology
  • [MeSH-minor] Biopsy, Fine-Needle. Diagnosis, Differential. Edema / diagnosis. Female. Humans. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20156409.001).
  • [ISSN] 1603-6824
  • [Journal-full-title] Ugeskrift for laeger
  • [ISO-abbreviation] Ugeskr. Laeg.
  • [Language] dan
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


13. Narendra H, Tankshali RA: Prevalence and pattern of nodal metastasis in pT4 gingivobuccal cancers and its implications for treatment. Indian J Cancer; 2010 Jul-Sep;47(3):328-31
MedlinePlus Health Information. consumer health - Oral Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CONTEXT: The pattern of nodal spread in oral cancers is largely predictable and treatment of neck can be tailored with this knowledge.
  • Most studies available on the pattern are from the western world and for early cancers of the tongue and floor of the mouth.
  • [MeSH-major] Adenocarcinoma, Bronchiolo-Alveolar / epidemiology. Lung Neoplasms / epidemiology. Mouth Neoplasms / epidemiology. Neck Dissection. Neoplasms, Squamous Cell / epidemiology

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20587912.001).
  • [ISSN] 1998-4774
  • [Journal-full-title] Indian journal of cancer
  • [ISO-abbreviation] Indian J Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  •  go-up   go-down


14. Saif MW, Hashmi S: Successful amelioration of oxaliplatin-induced hyperexcitability syndrome with the antiepileptic pregabalin in a patient with pancreatic cancer. Cancer Chemother Pharmacol; 2008 Mar;61(3):349-54
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CASE PRESENTATION: A 54-year-old woman was undergoing chemotherapy with gemcitabine and oxaliplatin (GEMOX) for stage II-B pancreatic adenocarcinoma.
  • In addition to reassurance, pregabalin was prescribed for these myotonic symptoms at a dosage of 50 mg by mouth three times daily.
  • [MeSH-major] Adenocarcinoma / complications. Anticonvulsants / therapeutic use. Antineoplastic Agents / adverse effects. Organoplatinum Compounds / adverse effects. Pancreatic Neoplasms / complications. Psychomotor Agitation / drug therapy. gamma-Aminobutyric Acid / analogs & derivatives

  • Genetic Alliance. consumer health - Pancreatic cancer.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • Hazardous Substances Data Bank. PREGABALIN .
  • Hazardous Substances Data Bank. CALCIUM GLUCONATE .
  • Hazardous Substances Data Bank. DIPHENHYDRAMINE .
  • Hazardous Substances Data Bank. MAGNESIUM SULFATE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17849118.001).
  • [ISSN] 0344-5704
  • [Journal-full-title] Cancer chemotherapy and pharmacology
  • [ISO-abbreviation] Cancer Chemother. Pharmacol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Anticonvulsants; 0 / Antimetabolites, Antineoplastic; 0 / Antineoplastic Agents; 0 / Histamine H1 Antagonists; 0 / Organoplatinum Compounds; 04ZR38536J / oxaliplatin; 0W860991D6 / Deoxycytidine; 55JG375S6M / Pregabalin; 56-12-2 / gamma-Aminobutyric Acid; 7487-88-9 / Magnesium Sulfate; 8GTS82S83M / Diphenhydramine; B76N6SBZ8R / gemcitabine; SQE6VB453K / Calcium Gluconate
  •  go-up   go-down


15. Wahid A, Ahmad S, Sajjad M: Pattern of carcinoma of oral cavity reporting at dental department of Ayub medical college. J Ayub Med Coll Abbottabad; 2005 Jan-Mar;17(1):65-6
MedlinePlus Health Information. consumer health - Oral Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pattern of carcinoma of oral cavity reporting at dental department of Ayub medical college.
  • BACKGROUND: Carcinoma of oral cavity is amongst the first ten commonest malignancies in Pakistan.
  • Here we present a report of oral cancers received in this center over a period of 10 years.
  • METHODDS: This clinicopathological study consists of cases of carcinoma of oral cavity presenting to dentistry department of Ayub Medical College Abbottabad during 1993-2003.
  • The other 6 % lesions were histologically diagnosed as malignant melanoma, adenocarcinoma and acinar cell carcinoma.
  • [MeSH-major] Mouth Neoplasms

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15929532.001).
  • [ISSN] 1025-9589
  • [Journal-full-title] Journal of Ayub Medical College, Abbottabad : JAMC
  • [ISO-abbreviation] J Ayub Med Coll Abbottabad
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Pakistan
  •  go-up   go-down


16. Stulík J, Kozák J, Sebesta P, Vyskocil T, Kryl J, Pelichovská M: Total spondylectomy of C2: a new surgical technique. Acta Chir Orthop Traumatol Cech; 2007 Apr;74(2):79-90
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We decided to perform a radical surgery in a man, now 27 y. o., with solitary metastasis of thyroid adenocarcinoma.
  • In order to identify the space between the anterior arch of C1 and the C4 vertebral body, the Synframe retractor was inserted with one blade opening the mouth by pressure on the upper teeth and two blades pressing the tongue caudally.
  • [MeSH-major] Adenocarcinoma / secondary. Adenocarcinoma / surgery. Cervical Vertebrae / surgery. Orthopedic Procedures / methods. Spinal Neoplasms / secondary

  • MedlinePlus Health Information. consumer health - Neck Injuries and Disorders.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17493408.001).
  • [ISSN] 0001-5415
  • [Journal-full-title] Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca
  • [ISO-abbreviation] Acta Chir Orthop Traumatol Cech
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Czech Republic
  •  go-up   go-down


17. Sun G, Yang X, Tang E, Wen J, Lu M, Hu Q: The treatment of sublingual gland tumours. Int J Oral Maxillofac Surg; 2010 Sep;39(9):863-8
MedlinePlus Health Information. consumer health - Salivary Gland Disorders.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Adenoid cystic carcinoma was mainly of the histological type, and the other histological classifications included mucoepidermoid carcinoma, pleomorphic adenoma, myoepithelioma, oncocytoma and polymorphous low-grade adenocarcinoma.
  • For malignant sublingual gland tumours, early diagnosis and aggressive surgical treatment, especially for tumours with nerve involvement, is the key to improving prognosis.
  • Free radial forearm flap or pectoralis major myocutaneous flap are appropriate methods for mouth floor reconstruction.
  • [MeSH-minor] Adenocarcinoma / pathology. Adenocarcinoma / therapy. Adenoma, Oxyphilic / pathology. Adenoma, Oxyphilic / therapy. Adenoma, Pleomorphic / pathology. Adenoma, Pleomorphic / therapy. Adult. Aged. Carcinoma, Adenoid Cystic / pathology. Carcinoma, Adenoid Cystic / therapy. Carcinoma, Mucoepidermoid / pathology. Carcinoma, Mucoepidermoid / therapy. Female. Humans. Male. Middle Aged. Myoepithelioma / pathology. Myoepithelioma / therapy. Reconstructive Surgical Procedures / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
  • (PMID = 20605409.001).
  • [ISSN] 1399-0020
  • [Journal-full-title] International journal of oral and maxillofacial surgery
  • [ISO-abbreviation] Int J Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


18. Ahmed Z, Azad NS, Rauf F, Yaqoob N, Husain A, Ahsan A, Ahmed R, Kayani N, Pervez S, Hassan SH: Frequency of primary solid malignant neoplasms in different age groups as seen in our practice. J Ayub Med Coll Abbottabad; 2007 Jul-Sep;19(3):56-63
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the third decade, colorectal adenocarcinoma in males and infiltrating.
  • In the fourth decade, squamous cell carcinoma of oral cavity in males and infiltrating ductal carcinoma of breast in females.
  • In the fifth decade squamous cell carcinoma of oral cavity in males and infiltrating ductal carcinoma of breast in females.
  • In sixth decade, squamous cell carcinoma of oral cavity in males and infiltrating ductal carcinoma of breast in females and in the seventh decade, prostatic adenocarcinoma in males and infiltrating ductal carcinoma of the breast in females.
  • Above age of 70 years, the commonest malignant were again prostatic adenocarcinoma in males and infiltrating ductal carcinoma of breast in females.
  • [MeSH-minor] Adenocarcinoma / epidemiology. Adolescent. Adult. Age Distribution. Aged. Breast Neoplasms / epidemiology. Carcinoma, Ductal, Breast / epidemiology. Carcinoma, Squamous Cell / epidemiology. Child. Colorectal Neoplasms / epidemiology. Female. Hodgkin Disease / epidemiology. Humans. Kidney Neoplasms / epidemiology. Male. Middle Aged. Mouth Neoplasms / epidemiology. Osteosarcoma / epidemiology. Pakistan / epidemiology. Retrospective Studies. Sarcoma, Ewing / epidemiology. Wilms Tumor / epidemiology

  • MedlinePlus Health Information. consumer health - Cancer in Children.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18444593.001).
  • [ISSN] 1025-9589
  • [Journal-full-title] Journal of Ayub Medical College, Abbottabad : JAMC
  • [ISO-abbreviation] J Ayub Med Coll Abbottabad
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Pakistan
  •  go-up   go-down


19. Abdel-Galil K, Anand R, Pratt C, Oeppen B, Brennan P: Trismus: an unconventional approach to treatment. Br J Oral Maxillofac Surg; 2007 Jun;45(4):339-40

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 63 year-old man who had had an operation for adenocarcinoma of the left parotid gland presented with worsening trismus after the completion of radiotherapy.
  • None of the treatments given were successful so he resorted to a "home-made" approach, and succeeded in improving his mouth-opening by 18 mm.
  • [MeSH-minor] Adenocarcinoma / surgery. Humans. Male. Middle Aged. Parotid Neoplasms / surgery. Radiotherapy, Adjuvant. Range of Motion, Articular / physiology. Self Care. Temporomandibular Joint / physiopathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16375999.001).
  • [ISSN] 0266-4356
  • [Journal-full-title] The British journal of oral & maxillofacial surgery
  • [ISO-abbreviation] Br J Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


20. Loh KS, Barker E, Bruch G, O'Sullivan B, Brown DH, Goldstein DP, Gilbert RW, Gullane PJ, Irish JC: Prognostic factors in malignancy of the minor salivary glands. Head Neck; 2009 Jan;31(1):58-63
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Adenoid cystic carcinoma (46.8%), mucoepidermoid carcinoma (22.8%), and adenocarcinoma (18.7%) were the most common pathologies.
  • The most frequent sites of primary tumor were in the oral cavity (44.4%) and nasal cavity (40.4%).
  • [MeSH-major] Adenocarcinoma / mortality. Carcinoma, Adenoid Cystic / mortality. Carcinoma, Mucoepidermoid / mortality. Salivary Gland Neoplasms / mortality
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Disease-Free Survival. Female. Humans. Male. Middle Aged. Mouth / pathology. Multivariate Analysis. Nasal Cavity / pathology. Neoplasm Invasiveness. Neoplasm Recurrence, Local / epidemiology. Prognosis. Retrospective Studies. Salivary Glands, Minor / pathology. Survival Analysis. Young Adult

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2008 Wiley Periodicals, Inc. Head Neck, 2009.
  • (PMID = 18853449.001).
  • [ISSN] 1097-0347
  • [Journal-full-title] Head & neck
  • [ISO-abbreviation] Head Neck
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


21. Boonananwong S, Kongkathip B, Kongkathip N: First synthesis of 3,16,20-polyoxygenated cholestanes, new cytotoxic steroids from the gorgonian Leptogorgia sarmentosa. Steroids; 2008 Oct;73(11):1123-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Antitumor activity against three tumor cell lines (breast cancer, MCF7, lung cancer NCI and oral cancer KB) was evaluated.
  • [MeSH-minor] Adenocarcinoma / drug therapy. Animals. Antineoplastic Agents / therapeutic use. Breast Neoplasms / drug therapy. Carcinoma, Small Cell / drug therapy. Carcinoma, Squamous Cell / drug therapy. Cell Line, Tumor. Drug Evaluation, Preclinical. Humans. Inhibitory Concentration 50. Lung Neoplasms / drug therapy. Molecular Structure. Mouth Neoplasms / drug therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18550136.001).
  • [ISSN] 0039-128X
  • [Journal-full-title] Steroids
  • [ISO-abbreviation] Steroids
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Cholestanes; 0 / Cytotoxins; 0 / Steroids
  •  go-up   go-down


22. De Riu G, Meloni SM, Bozzo C, Meloni F, Tullio A: A double buccal fat pad flap for middle palate defect closure--a new technique for palate closure. Int J Oral Maxillofac Surg; 2006 Nov;35(11):1057-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The technique is described in a case of adenocarcinoma arising from the nasal septum and its indications and advantages are discussed.
  • [MeSH-major] Adenocarcinoma / surgery. Adipose Tissue / transplantation. Osteotomy, Le Fort / methods. Palatal Neoplasms / surgery. Palate / surgery. Surgical Flaps
  • [MeSH-minor] Female. Humans. Middle Aged. Mouth Mucosa / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16828541.001).
  • [ISSN] 0901-5027
  • [Journal-full-title] International journal of oral and maxillofacial surgery
  • [ISO-abbreviation] Int J Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


23. Toida M, Shimokawa K, Makita H, Kato K, Kobayashi A, Kusunoki Y, Hatakeyama D, Fujitsuka H, Yamashita T, Shibata T: Intraoral minor salivary gland tumors: a clinicopathological study of 82 cases. Int J Oral Maxillofac Surg; 2005 Jul;34(5):528-32
MedlinePlus Health Information. consumer health - Salivary Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The tumors affected the palate (n = 64), the buccal region (n = 10), the upper lip (n = 6), the floor of the mouth (n = 1), and the retromolar region (n = 1).
  • Histologically, the tumors were classified as pleomorphic adenoma (n = 54), papillary cystadenoma (n = 1), adenoid cystic carcinoma (n = 10), mucoepidermoid carcinoma (n = 8), acinic cell carcinoma (n = 3), adenocarcinoma (n = 2), basal cell adenocarcinoma (n = 1), papillary cystadenocarcinoma (n = 1), and carcinoma in pleomorphic adenoma (n = 2).
  • From the results of the present study and review of the literature, it is suggested that the minor salivary gland tumors in Japan may be characterized by a higher incidence of benign tumors, especially of pleomorphic adenoma; a more marked tendency for female predominance; a higher incidence of palatal involvement; and a rarer occurrence of polymorphous low grade adenocarcinoma, in comparison with those reported in the literature from outside of Japan.
  • [MeSH-minor] Adenocarcinoma / epidemiology. Adenoma, Pleomorphic / epidemiology. Adolescent. Adult. Aged. Aged, 80 and over. Carcinoma, Adenoid Cystic / epidemiology. Carcinoma, Mucoepidermoid / epidemiology. Cheek / pathology. Child. Female. Humans. Japan / epidemiology. Lip / pathology. Male. Middle Aged. Palate / pathology. Retrospective Studies. Sex Factors

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16053873.001).
  • [ISSN] 0901-5027
  • [Journal-full-title] International journal of oral and maxillofacial surgery
  • [ISO-abbreviation] Int J Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


24. Kim YW, Baik YH, Yun YH, Nam BH, Kim DH, Choi IJ, Bae JM: Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial. Ann Surg; 2008 Nov;248(5):721-7
ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Most of the scales on patient functioning including physical (P < 0.0005), role (P = 0.0011), emotional (P < 0.0001), social (P < 0.0001), and symptom scales such as fatigue (P < 0.0001), pain (P < 0.0001), appetite loss (P = 0.031), sleep disturbance (P = 0.003), dysphasia (P = 0.0024), gastro-esophageal reflux (P = 0.0127), dietary restriction (P = 0.0004), anxiety (P = 0.0036), dry mouth (P = 0.0007), and body image (P < 0.0001) were also significantly better in the LADG group compared with the ODG group.
  • [MeSH-major] Adenocarcinoma / surgery. Gastrectomy / methods. Quality of Life. Stomach Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Ann Surg. 2009 Aug;250(2):349-50; author reply 350 [19648806.001]
  • (PMID = 18948798.001).
  • [ISSN] 1528-1140
  • [Journal-full-title] Annals of surgery
  • [ISO-abbreviation] Ann. Surg.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


25. Campos MS, Modolo F, de Oliveira JS, Pinto-Júnior DS, de Sousa SC: Atypical presentation of oral basaloid squamous cell carcinoma. J Contemp Dent Pract; 2009;10(2):98-104
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Atypical presentation of oral basaloid squamous cell carcinoma.
  • SUMMARY: Since this tumor can mimic other neoplasms such as adenoid cystic carcinoma, neuroendocrine carcinoma, and basal cell adenocarcinoma, histological features are essential to differentiate between them.
  • Clinicians are advised to conduct a mucosal evaluation during oral examinations and take a thorough medical history which could ultimately save the life of a patient.
  • [MeSH-major] Carcinoma, Squamous Cell / diagnosis. Carcinoma, Transitional Cell / diagnosis. Mouth Neoplasms / diagnosis
  • [MeSH-minor] Adenocarcinoma / diagnosis. Carcinoma, Adenoid Cystic / diagnosis. Carcinoma, Neuroendocrine / diagnosis. Cell Nucleus / ultrastructure. Diagnosis, Differential. Follow-Up Studies. Humans. Immunohistochemistry. Keratins / analysis. Ki-67 Antigen / analysis. Laminin / analysis. Male. Middle Aged. Mitosis. Necrosis. Tumor Suppressor Protein p53 / analysis

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • Genetic Alliance. consumer health - Oral squamous cell carcinoma.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19279978.001).
  • [ISSN] 1526-3711
  • [Journal-full-title] The journal of contemporary dental practice
  • [ISO-abbreviation] J Contemp Dent Pract
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Ki-67 Antigen; 0 / Laminin; 0 / Tumor Suppressor Protein p53; 68238-35-7 / Keratins
  •  go-up   go-down


26. Hussain SK, Sundquist J, Hemminki K: Familial clustering of cancer at human papillomavirus-associated sites according to the Swedish Family-Cancer Database. Int J Cancer; 2008 Apr 15;122(8):1873-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Offspring cancer risk was significantly increased when either a sibling or parent was affected at the same site for penile squamous cell carcinoma (SCC, SIR = 7.54), cervical adenocarcinoma (AC, SIR = 2.31), vulvar SCC (SIR = 2.27), skin SCC (SIR = 2.14), rectal AC (SIR = 1.86), in situ cervical SCC (SIR = 1.80), invasive cervical SCC (SIR = 1.77) and upper aerodigestive tract SCC (SIR = 1.57).
  • [MeSH-minor] Adenocarcinoma / epidemiology. Adult. Aged. Anus Neoplasms / epidemiology. Carcinoma in Situ / epidemiology. Carcinoma, Squamous Cell / epidemiology. Cluster Analysis. Family. Female. Humans. Incidence. Male. Medical Record Linkage. Middle Aged. Mouth Neoplasms / epidemiology. Odds Ratio. Papillomavirus Infections / complications. Papillomavirus Infections / virology. Pharyngeal Neoplasms / epidemiology. Registries. Sweden / epidemiology. Tonsillar Neoplasms / epidemiology. Tumor Virus Infections / complications. Tumor Virus Infections / virology. Uterine Cervical Neoplasms / epidemiology. Vulvar Neoplasms / epidemiology

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18074353.001).
  • [ISSN] 1097-0215
  • [Journal-full-title] International journal of cancer
  • [ISO-abbreviation] Int. J. Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


27. Liu N, Liang H, Li Q, Wang DC, Zhang RP, Wang JC, Hao XS: [Determinants of long-term survival in 38 patients with carcinoma of ampulla of Vater treated by local resection]. Zhonghua Zhong Liu Za Zhi; 2005 Oct;27(10):629-31

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Meticulous care was taken not to suture the pancreatic duct and endotheliation was ensured at the mouth of common bile duct and duodenum.
  • [MeSH-major] Adenocarcinoma / surgery. Ampulla of Vater / surgery. Common Bile Duct Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16438877.001).
  • [ISSN] 0253-3766
  • [Journal-full-title] Zhonghua zhong liu za zhi [Chinese journal of oncology]
  • [ISO-abbreviation] Zhonghua Zhong Liu Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


28. Wu MH, Hong TM, Cheng HW, Pan SH, Liang YR, Hong HC, Chiang WF, Wong TY, Shieh DB, Shiau AL, Jin YT, Chen YL: Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons. Mol Cancer Res; 2009 Mar;7(3):311-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Gal-1 is highly expressed in the invasive front of primary tumors and in the cancer cells of metastatic lesions in the lymph nodes of patients with oral squamous cell carcinoma.
  • We found that increased Gal-1 expression is closely associated with its high levels of invasion in lung adenocarcinoma and oral squamous cell carcinoma cell lines.
  • We conclude that Gal-1 is involved in tumor invasion and metastasis by increasing MMP expression and reorganizing cytoskeletons in oral cancers and lung adenocarcinoma.
  • [MeSH-minor] Adenocarcinoma / genetics. Adenocarcinoma / metabolism. Adenocarcinoma / pathology. Animals. Carcinoma, Squamous Cell / genetics. Carcinoma, Squamous Cell / metabolism. Carcinoma, Squamous Cell / pathology. Cell Line, Tumor. Cytoskeleton / metabolism. Humans. Lung Neoplasms / genetics. Lung Neoplasms / metabolism. Lung Neoplasms / pathology. Male. Mice. Mouth Neoplasms / genetics. Mouth Neoplasms / metabolism. Mouth Neoplasms / pathology. Neoplasm Invasiveness. RNA, Small Interfering / genetics. Up-Regulation. rho GTP-Binding Proteins / metabolism

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19276182.001).
  • [ISSN] 1541-7786
  • [Journal-full-title] Molecular cancer research : MCR
  • [ISO-abbreviation] Mol. Cancer Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 0 / Galectin 1; 0 / RNA, Small Interfering; EC 3.4.24.24 / Matrix Metalloproteinase 2; EC 3.4.24.35 / Matrix Metalloproteinase 9; EC 3.6.5.2 / rho GTP-Binding Proteins
  •  go-up   go-down


29. Hu YH, Li J: [Clear cell carcinoma of salivary gland: a clinicopathologic study of 10 cases]. Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Jan;40(1):54-7
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Seven tumors were from palate, one was from base of tongue, one in retromolar region, and one in floor of mouth.
  • [MeSH-major] Adenocarcinoma, Clear Cell / pathology. Salivary Gland Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15774154.001).
  • [ISSN] 1002-0098
  • [Journal-full-title] Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology
  • [ISO-abbreviation] Zhonghua Kou Qiang Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  •  go-up   go-down


30. Mathis S, Fromont-Hankard G, du Boisguéheneuc F, Godenèche G, Mahieu F, Balaboi I, Nocon C, Marsac E, Neau JP: [Muscular metastasis]. Rev Neurol (Paris); 2010 Mar;166(3):295-304

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHOD: Our work was a retrospective study with analysis of the medical literature and the presentation of one case of muscular metastasis revealed by a limitation of mouth opening in a 58-year-old Caucasian man (metastatic infiltration of the right pterygoid muscle secondary to a poorly differentiated adenocarcinoma of the lower third of the esophagus).
  • The muscular metastasis were rarely found before the diagnosis of cancer (only in 37%), and usually appeared during disease progression, with other (extramuscular) metastases in 60% of cases.
  • When the muscular biopsy showed an "adenocarcinoma", in men the primitive cancers were localized in the digestive tract (35%), kidney (20%), and lung (18%) and in women, the genital tract and breast (23.5%).
  • [MeSH-major] Adenocarcinoma / secondary. Muscle Neoplasms / secondary

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2009 Elsevier Masson SAS. All rights reserved.
  • (PMID = 19732922.001).
  • [ISSN] 0035-3787
  • [Journal-full-title] Revue neurologique
  • [ISO-abbreviation] Rev. Neurol. (Paris)
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


31. Suedmeyer WK, Johnson G: Survey of neoplasia in red kangaroos (Macropus rufus), 1992-2002, in a zoological collection. J Zoo Wildl Med; 2007 Jun;38(2):231-9
MedlinePlus Health Information. consumer health - Stomach Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Two squamous cell carcinomas of the oral cavity, two mammary gland adenocarcinomas, a multicentric T-cell lymphosarcoma, and one submucosal pyloric lipoma were diagnosed in six of 28 kangaroo deaths.
  • On the basis of these cases and a review of the literature, the most commonly observed neoplasms in red kangaroos are mammary gland adenocarcinomas and oral squamous cell carcinomas.
  • Common denominators were not identified in these cases, although chronic gingivitis could have been a contributing factor in the development of the oral squamous cell carcinomas.
  • [MeSH-major] Lymphoma, Non-Hodgkin / veterinary. Macropodidae. Mammary Neoplasms, Animal / epidemiology. Mouth Neoplasms / veterinary. Stomach Neoplasms / veterinary
  • [MeSH-minor] Adenocarcinoma / epidemiology. Adenocarcinoma / mortality. Adenocarcinoma / pathology. Adenocarcinoma / veterinary. Animals. Animals, Zoo. Carcinoma, Squamous Cell / epidemiology. Carcinoma, Squamous Cell / mortality. Carcinoma, Squamous Cell / pathology. Carcinoma, Squamous Cell / veterinary. Female. Immunohistochemistry / veterinary. Lipoma / epidemiology. Lipoma / mortality. Lipoma / pathology. Lipoma / veterinary. T-Lymphocytes / pathology

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17679506.001).
  • [ISSN] 1042-7260
  • [Journal-full-title] Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians
  • [ISO-abbreviation] J. Zoo Wildl. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


32. Gomes CC, Lacerda JC, Pimenta FJ, do Carmo MA, Gomez RS: Intraoral sebaceous carcinoma. Eur Arch Otorhinolaryngol; 2007 Jul;264(7):829-32
MedlinePlus Health Information. consumer health - Oral Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Intraoral sebaceous carcinoma (SC) is a rare tumour in the oral cavity thought to arise from malignant transformation of oral sebaceous glands.
  • [MeSH-major] Adenocarcinoma, Sebaceous / diagnosis. Mouth Neoplasms / diagnosis. Sebaceous Gland Neoplasms / diagnosis
  • [MeSH-minor] Biopsy. Combined Modality Therapy. Diagnosis, Differential. Follow-Up Studies. Humans. Male. Middle Aged. Radiography, Panoramic. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17285332.001).
  • [ISSN] 0937-4477
  • [Journal-full-title] European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
  • [ISO-abbreviation] Eur Arch Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


33. Werbrouck J, De Ruyck K, Duprez F, Veldeman L, Claes K, Van Eijkeren M, Boterberg T, Willems P, Vral A, De Neve W, Thierens H: Acute normal tissue reactions in head-and-neck cancer patients treated with IMRT: influence of dose and association with genetic polymorphisms in DNA DSB repair genes. Int J Radiat Oncol Biol Phys; 2009 Mar 15;73(4):1187-95
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: The mean dose (D(mean)) to the oral cavity and constrictor pharyngeus (PC) muscles was significantly associated with the development of mucositis and dysphagia, respectively.
  • [MeSH-minor] Adenocarcinoma / genetics. Adenocarcinoma / radiotherapy. Adult. Aged. Aged, 80 and over. Antigens, Nuclear / genetics. Arabidopsis Proteins / genetics. Carcinoma, Squamous Cell / genetics. Carcinoma, Squamous Cell / radiotherapy. DNA Ligases / genetics. DNA-Binding Proteins / genetics. Female. Humans. Male. Middle Aged. Mouth / radiation effects. Mouth Mucosa / radiation effects. Pharyngeal Muscles / radiation effects. Rad51 Recombinase / genetics. Radiodermatitis / genetics. Radiotherapy Dosage. Regression Analysis

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Swallowing Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19251090.001).
  • [ISSN] 1879-355X
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Nuclear; 0 / Arabidopsis Proteins; 0 / DNA-Binding Proteins; 0 / Ku autoantigen; 0 / X-ray repair cross complementing protein 3; EC 2.7.7.- / ATRAD51 protein, Arabidopsis; EC 2.7.7.- / Rad51 Recombinase; EC 6.5.1.- / DNA Ligases; EC 6.5.1.1 / DNA ligase (ATP)
  •  go-up   go-down


34. Adelson RT, DeFatta RJ, Miles BA, Hoblitt SL, Ducic Y: Metastatic breast cancer of the oral cavity. Am J Otolaryngol; 2005 Jul-Aug;26(4):279-81
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastatic breast cancer of the oral cavity.
  • OBJECTIVE: To present a rare case of breast carcinoma initially presenting as an oral cavity mass.
  • CONCLUSIONS: Metastatic disease to the oral cavity represents only 1% of all oral cavity malignancies.
  • [MeSH-major] Adenocarcinoma / secondary. Breast Neoplasms / pathology. Mouth Neoplasms / secondary


35. Munir N, Bradley PJ: Diagnosis and management of neoplastic lesions of the submandibular triangle. Oral Oncol; 2008 Mar;44(3):251-60
MedlinePlus Health Information. consumer health - Oral Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diagnosis and management of neoplastic lesions of the submandibular triangle.
  • Definitive diagnosis was by excision and pathological examination.
  • Malignant tumours have a poor symptomatology that can result in late (often post-operative) diagnosis.
  • [MeSH-major] Mouth Neoplasms / diagnosis
  • [MeSH-minor] Adenocarcinoma / diagnosis. Adenocarcinoma / surgery. Adenoma, Pleomorphic / diagnosis. Adenoma, Pleomorphic / surgery. Adolescent. Adult. Aged. Aged, 80 and over. Carcinoma, Squamous Cell / diagnosis. Carcinoma, Squamous Cell / surgery. Child. Female. Humans. Lymphoma, Non-Hodgkin / diagnosis. Lymphoma, Non-Hodgkin / surgery. Male. Middle Aged. Retrospective Studies. Submandibular Gland Neoplasms / diagnosis. Submandibular Gland Neoplasms / surgery. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17467329.001).
  • [ISSN] 1368-8375
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


36. Mahlen SD, Clarridge JE 3rd: Oral abscess caused by Campylobacter rectus: case report and literature review. J Clin Microbiol; 2009 Mar;47(3):848-51
SILVA. SILVA SSU Database .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Oral abscess caused by Campylobacter rectus: case report and literature review.
  • Campylobacter rectus was isolated under routine anaerobic conditions (no additional hydrogen gas in the atmosphere) from an oral, nonperiodontal abscess from a patient with gastroesophageal adenocarcinoma.
  • [MeSH-major] Abscess / microbiology. Campylobacter Infections / diagnosis. Campylobacter rectus / isolation & purification. Mouth Diseases / microbiology

  • MedlinePlus Health Information. consumer health - Abscess.
  • MedlinePlus Health Information. consumer health - Campylobacter Infections.
  • MedlinePlus Health Information. consumer health - Mouth Disorders.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Dent Res. 2000 Feb;79(2):785-92 [10728981.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 2008 Nov;27(11):1119-23 [18488257.001]
  • [Cites] J Clin Periodontol. 1979 Oct;6(5):278-307 [294457.001]
  • [Cites] J Periodontal Res. 1984 May;19(3):279-91 [6235344.001]
  • [Cites] J Clin Microbiol. 1984 Dec;20(6):1187-9 [6520225.001]
  • [Cites] Infect Immun. 1985 May;48(2):507-19 [3988344.001]
  • [Cites] J Clin Periodontol. 1989 Aug;16(7):467-71 [2768541.001]
  • [Cites] Int J Syst Bacteriol. 1991 Jan;41(1):88-103 [1704793.001]
  • [Cites] J Periodontal Res. 1992 Jan;27(1):8-14 [1531512.001]
  • [Cites] Int J Syst Bacteriol. 1993 Oct;43(4):631-9 [7694633.001]
  • [Cites] Oral Microbiol Immunol. 1993 Aug;8(4):230-5 [8247610.001]
  • [Cites] J Clin Periodontol. 1998 Feb;25(2):85-98 [9495607.001]
  • [Cites] J Clin Microbiol. 2005 May;43(5):2513-5 [15872299.001]
  • [Cites] J Med Microbiol. 2006 May;55(Pt 5):609-15 [16585650.001]
  • [Cites] J Periodontol. 2007 Jun;78(6):1051-61 [17539719.001]
  • [Cites] J Clin Microbiol. 2007 Aug;45(8):2446-51 [17567788.001]
  • [Cites] J Chemother. 2007 Oct;19(5):495-9 [18073147.001]
  • [Cites] Int Endod J. 2003 Mar;36(3):174-80 [12657143.001]
  • (PMID = 19109480.001).
  • [ISSN] 1098-660X
  • [Journal-full-title] Journal of clinical microbiology
  • [ISO-abbreviation] J. Clin. Microbiol.
  • [Language] eng
  • [Databank-accession-numbers] GENBANK/ EU743946
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Bacterial; 0 / DNA, Ribosomal; 0 / RNA, Ribosomal, 16S
  • [Other-IDs] NLM/ PMC2650927
  •  go-up   go-down


37. Kleinschmidt S, Puff C, Baumgärtner W: Metastasizing oral squamous cell carcinoma in an aged pig. Vet Pathol; 2006 Jul;43(4):569-73
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastasizing oral squamous cell carcinoma in an aged pig.
  • Clinical examination revealed a mass in the left part of the oral cavity extending from the hard to the soft palate.
  • Additional findings included a uterine adenocarcinoma, a hepatocellular adenoma, and nodular hyperplasias in spleen and adrenal glands.
  • Histologically, the poorly demarcated, infiltrative growing oral mass consisted of islands, cords, and single epithelial cells with moderate squamous differentiation.
  • The present findings represent the first report of a metastasizing oral squamous cell carcinoma in a pig.
  • [MeSH-major] Carcinoma, Squamous Cell / veterinary. Mouth Neoplasms / veterinary. Swine Diseases / pathology

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16847003.001).
  • [ISSN] 0300-9858
  • [Journal-full-title] Veterinary pathology
  • [ISO-abbreviation] Vet. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 68238-35-7 / Keratins
  •  go-up   go-down


38. Ng SY, Songra AK, Hutchison IL: Novel use of ultrasound-guided surface marking of head and neck tumors invading facial skin. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr;101(4):499-504
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma / ultrastructure. Carcinoma, Squamous Cell / ultrasonography. Facial Neoplasms / ultrasonography. Head and Neck Neoplasms / pathology. Reconstructive Surgical Procedures / methods
  • [MeSH-minor] Adult. Cheek. Edema / ultrasonography. Female. Forehead. Humans. Ink. Middle Aged. Mouth Mucosa / pathology. Neoplasm Invasiveness / pathology. Neoplasm Invasiveness / ultrastructure. Neoplasm Recurrence, Local / pathology. Neoplasm Recurrence, Local / ultrastructure. Neoplasms, Second Primary / pathology. Neoplasms, Second Primary / surgery. Neoplasms, Second Primary / ultrasonography. Patient Care Planning. Skin Neoplasms / pathology. Skin Neoplasms / surgery. Skin Neoplasms / ultrasonography. Surgical Flaps

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16545715.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


39. Yadav DS, Devi TR, Ihsan R, Mishra AK, Kaushal M, Chauhan PS, Bagadi SA, Sharma J, Zamoawia E, Verma Y, Nandkumar A, Saxena S, Kapur S: Polymorphisms of glutathione-S-transferase genes and the risk of aerodigestive tract cancers in the Northeast Indian population. Genet Test Mol Biomarkers; 2010 Oct;14(5):715-23
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Samples from 370 cases with oral, gastric, and lung cancers and 270 controls were analyzed for polymorphism of glutathione-S-transferase (GST) genes using polymerase chain reaction-restriction fragment length polymorphism-based methods.
  • RESULTS AND CONCLUSIONS: Tobacco smoking and betel quid chewing were found to be high risk factors for oral and lung cancers but not for gastric cancer, whereas tobacco chewing was found to be a risk factor for oral cancer but not for gastric or lung cancer.
  • GSTT1 and GSTM1 null genotypes appeared to play a protective role for lung cancer (odds ratio [OR] = 0.47, 95% confidence interval [95% CI]: 0.24-0.93, p = 0.03) and (OR = 0.52, 95% CI: 0.28-0.96, p = 0.04), but they were not associated with oral and gastric cancers.
  • However, when data was analyzed in different geographic regions the GSTT1 null genotype was found to be a significant risk factor for oral (OR = 2.58, 95% CI 1.01-6.61, p = 0.05) as well as gastric cancer (OR = 3.08, 95% CI 1.32-7.19, p = 0.009) in samples obtained from the Assam region of NE India.
  • [MeSH-major] Adenocarcinoma / genetics. Carcinoma, Squamous Cell / genetics. Glutathione S-Transferase pi / genetics. Glutathione Transferase / genetics. Lung Neoplasms / genetics. Mouth Neoplasms / genetics. Polymorphism, Single Nucleotide. Stomach Neoplasms / genetics

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20854097.001).
  • [ISSN] 1945-0257
  • [Journal-full-title] Genetic testing and molecular biomarkers
  • [ISO-abbreviation] Genet Test Mol Biomarkers
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Carcinogens; EC 2.5.1.- / glutathione S-transferase T1; EC 2.5.1.18 / GSTP1 protein, human; EC 2.5.1.18 / Glutathione S-Transferase pi; EC 2.5.1.18 / Glutathione Transferase; EC 2.5.1.18 / glutathione S-transferase M1
  •  go-up   go-down


40. Schoppmeyer K, Kreth F, Wiedmann M, Mössner J, Preiss R, Caca K: A pilot study of bendamustine in advanced bile duct cancer. Anticancer Drugs; 2007 Jul;18(6):697-702
Hazardous Substances Data Bank. Bendamustine .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Six patients with histologically proven, unresectable adenocarcinoma of the hilar bile duct were treated with bendamustine 140 mg/m intravenously on day 1 of the first cycle and with bendamustine 100 mg/m on days 1 and 2 of the second to fourth cycle.
  • The most common nonhematologic toxicity was mouth dryness grade 2 in six patients.
  • [MeSH-major] Adenocarcinoma / drug therapy. Antineoplastic Agents. Bile Duct Neoplasms / drug therapy. Nitrogen Mustard Compounds

  • MedlinePlus Health Information. consumer health - Bile Duct Cancer.
  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17762399.001).
  • [ISSN] 0959-4973
  • [Journal-full-title] Anti-cancer drugs
  • [ISO-abbreviation] Anticancer Drugs
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Nitrogen Mustard Compounds; 981Y8SX18M / Bendamustine Hydrochloride
  •  go-up   go-down


41. Alawi F, Siddiqui A: Sebaceous carcinoma of the oral mucosa: case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Jan;99(1):79-84
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sebaceous carcinoma of the oral mucosa: case report and review of the literature.
  • Fordyce granules are found in the oral mucosa of up to 80% of adults.
  • However, primary malignant sebaceous tumors of the oral mucosa are exceedingly rare.
  • [MeSH-major] Adenocarcinoma, Sebaceous / pathology. Lip Neoplasms / pathology
  • [MeSH-minor] Aged. Biopsy. Choristoma / pathology. Diagnosis, Differential. Follow-Up Studies. Humans. Male. Mouth Diseases / pathology. Mouth Mucosa / pathology. Mucin-1 / analysis. Receptors, Androgen / analysis. Sebaceous Glands / pathology. Sweat Glands / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15599352.001).
  • [ISSN] 1079-2104
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Mucin-1; 0 / Receptors, Androgen
  • [Number-of-references] 42
  •  go-up   go-down


42. Hu SC, Chen GS, Wu CS, Chai CY, Chen WT, Lan CC: Rates of cutaneous metastases from different internal malignancies: experience from a Taiwanese medical center. J Am Acad Dermatol; 2009 Mar;60(3):379-87
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The highest rates of skin metastases were found to occur from carcinoma of the breast, followed by the lung, oral mucosa, colon and rectum, stomach, and esophagus.
  • [MeSH-major] Adenocarcinoma / ethnology. Adenocarcinoma / secondary. Breast Neoplasms / ethnology. Breast Neoplasms / pathology. Skin Neoplasms / ethnology. Skin Neoplasms / secondary
  • [MeSH-minor] Academic Medical Centers / statistics & numerical data. Asian Continental Ancestry Group / statistics & numerical data. Carcinoma, Hepatocellular / ethnology. Carcinoma, Hepatocellular / metabolism. Carcinoma, Hepatocellular / secondary. Carcinoma, Squamous Cell / ethnology. Carcinoma, Squamous Cell / metabolism. Carcinoma, Squamous Cell / secondary. Carcinoma, Transitional Cell / ethnology. Carcinoma, Transitional Cell / metabolism. Carcinoma, Transitional Cell / secondary. Gastrointestinal Neoplasms / ethnology. Gastrointestinal Neoplasms / metabolism. Gastrointestinal Neoplasms / pathology. Humans. Immunohistochemistry. Liver Neoplasms / ethnology. Liver Neoplasms / metabolism. Liver Neoplasms / pathology. Lung Neoplasms / ethnology. Lung Neoplasms / metabolism. Lung Neoplasms / pathology. Mouth Neoplasms / ethnology. Mouth Neoplasms / metabolism. Mouth Neoplasms / pathology. Receptors, CCR10 / metabolism. Receptors, CXCR4 / metabolism. Retrospective Studies. Taiwan / epidemiology. Urinary Bladder Neoplasms / ethnology. Urinary Bladder Neoplasms / metabolism. Urinary Bladder Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19056145.001).
  • [ISSN] 1097-6787
  • [Journal-full-title] Journal of the American Academy of Dermatology
  • [ISO-abbreviation] J. Am. Acad. Dermatol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CCR10 protein, human; 0 / CXCR4 protein, human; 0 / Receptors, CCR10; 0 / Receptors, CXCR4
  •  go-up   go-down


43. Desai SC, Sung CK, Genden EM: Transoral robotic surgery using an image guidance system. Laryngoscope; 2008 Nov;118(11):2003-5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Final pathology of a vascular malformation, an acinic cell adenocarcinoma, and a squamous cell carcinoma were located and minimally invasively removed by a transoral robotic approach with the aid of image guidance.
  • [MeSH-minor] Adenocarcinoma / diagnosis. Adenocarcinoma / surgery. Aged. Biopsy, Needle. Carcinoma, Squamous Cell / diagnosis. Carcinoma, Squamous Cell / surgery. Female. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Mouth. Pharynx / blood supply. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18849862.001).
  • [ISSN] 1531-4995
  • [Journal-full-title] The Laryngoscope
  • [ISO-abbreviation] Laryngoscope
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


44. Giannini PJ, Shetty KV, Horan SL, Reid WD, Litchmore LL: Adenoid cystic carcinoma of the buccal vestibule: A case report and review of the literature. Oral Oncol; 2006 Nov;42(10):1029-32
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Adenoid cystic carcinoma is the fifth most common salivary gland malignancy following mucoepidermoid carcinoma, adenocarcinoma not otherwise specified (NOS), acinic cell adenocarcinoma and polymorphous low-grade adenocarcinoma (PLGA).
  • [MeSH-major] Carcinoma, Adenoid Cystic / pathology. Mouth Neoplasms / pathology. Salivary Gland Neoplasms / pathology
  • [MeSH-minor] Female. Humans. Middle Aged. Mouth Mucosa. Salivary Glands, Minor


45. Brusevold IJ, Søland TM, Khuu C, Christoffersen T, Bryne M: Nuclear and cytoplasmic expression of Met in oral squamous cell carcinoma and in an organotypic oral cancer model. Eur J Oral Sci; 2010 Aug;118(4):342-9
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nuclear and cytoplasmic expression of Met in oral squamous cell carcinoma and in an organotypic oral cancer model.
  • The aim of this study was to examine the pattern of Met expression and its value as a prognostic factor in oral squamous cell carcinomas (OSCCs).
  • The material consisted of 53 OSCCs and five healthy controls from normal oral mucosa supplied with cell lines, 10 organotypic models supplied with oral cancer cells, and three organotypic models supplied with normal keratinocytes.
  • Met expression was scarce and limited to the basal layer in normal oral mucosa, but was more extensive in the tumours.
  • Organotypic models with normal or malignant oral cells yielded principally similar results as in the mucosa and the cancers, respectively.
  • A smaller amount of Met immunoreactivity was detected, by western blotting, in the nuclear fraction of cultured oral cancer cells.
  • [MeSH-major] Carcinoma, Squamous Cell / pathology. Cell Nucleus / ultrastructure. Cytoplasm / ultrastructure. Mouth Neoplasms / pathology. Proto-Oncogene Proteins c-met / analysis
  • [MeSH-minor] Adenocarcinoma / pathology. Biomarkers, Tumor / analysis. Breast Neoplasms / pathology. Carcinoma / pathology. Cell Culture Techniques. Cell Line. Cells, Cultured. Coculture Techniques. Female. Fibroblasts / cytology. Gingiva / cytology. Humans. Keratinocytes / cytology. Keratins / analysis. Male. Middle Aged. Mouth Mucosa / cytology. Neoplasm Invasiveness. Prognosis. Skin Neoplasms / pathology. Tissue Scaffolds. Tongue Neoplasms / pathology. Up-Regulation


46. Sugiyama T, Nakagawa T, Narita M, Nakamura S, Inui M, Tagawa T: Pedunculated oncocytic carcinoma in buccal mucosa: immunohistochemical and ultrastructural studies. Oral Dis; 2006 May;12(3):324-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • An incision biopsy revealed the diagnosis of oncocytic tumor, and enucleation was performed.
  • CONCLUSIONS: Because the histopathologic features of OC are similar to those of benign oncocytoma, the diagnosis of OC must be confirmed by a combination of clinical and ultrastructural characteristics.
  • [MeSH-major] Adenocarcinoma / pathology. Mouth Neoplasms / pathology
  • [MeSH-minor] Aged, 80 and over. Cheek / pathology. Humans. Immunohistochemistry. Keratins / analysis. Male. Microscopy, Electron, Transmission. Mitochondria / pathology. Mouth Mucosa / pathology. Mucin-1 / analysis. Neoplasm Invasiveness

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16700744.001).
  • [ISSN] 1354-523X
  • [Journal-full-title] Oral diseases
  • [ISO-abbreviation] Oral Dis
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Mucin-1; 68238-35-7 / Keratins
  •  go-up   go-down


47. Lloyd S, Yu JB, Ross DA, Wilson LD, Decker RH: A prognostic index for predicting lymph node metastasis in minor salivary gland cancer. Int J Radiat Oncol Biol Phys; 2010 Jan 1;76(1):169-75
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Factors associated with neck nodal involvement on univariate analysis included increasing age, male sex, increasing tumor size, high tumor grade, T3-T4 stage, adenocarcinoma or mucoepidermoid carcinomas, and pharyngeal site of primary malignancy.
  • On multivariate analysis, four statistically significant factors were identified, including male sex, T3-T4 stage, pharyngeal site of primary malignancy, and high-grade adenocarcinoma or high-grade mucoepidermoid carcinomas.
  • Grade was a significant predictor of metastasis for adenocarcinoma and mucoepidermoid carcinoma but not for adenoid cystic carcinoma.
  • [MeSH-major] Adenocarcinoma / secondary. Salivary Gland Neoplasms / pathology. Salivary Glands, Minor / pathology
  • [MeSH-minor] Age Factors. Analysis of Variance. Carcinoma, Acinar Cell / pathology. Carcinoma, Acinar Cell / secondary. Carcinoma, Adenoid Cystic / pathology. Carcinoma, Adenoid Cystic / secondary. Carcinoma, Mucoepidermoid / pathology. Carcinoma, Mucoepidermoid / secondary. Chi-Square Distribution. Female. Humans. Laryngeal Neoplasms / pathology. Lymphatic Metastasis. Male. Middle Aged. Mouth Neoplasms / pathology. Neck. Neck Dissection. Neoplasm Staging. Nose Neoplasms / pathology. Pharyngeal Neoplasms / pathology. Prognosis. SEER Program. Sex Factors. Tumor Burden

  • Genetic Alliance. consumer health - Salivary Gland Cancer.
  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19386433.001).
  • [ISSN] 1879-355X
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Grant] United States / NCRR NIH HHS / RR / UL1 RR024139
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  •  go-up   go-down


48. Wang H, Yao J, Solomon M, Axiotis CA: Sebaceous carcinoma of the oral cavity: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Aug;110(2):e37-40
MedlinePlus Health Information. consumer health - Oral Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sebaceous carcinoma of the oral cavity: a case report and review of the literature.
  • We discuss the differential diagnosis and histogenesis.
  • [MeSH-major] Adenocarcinoma, Sebaceous / pathology. Mouth Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Mosby, Inc. All rights reserved.
  • (PMID = 20659693.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Receptors, Androgen
  •  go-up   go-down


49. Papadogeorgakis N, Petsinis V, Goutzanis L, Kostakis G, Alexandridis C: Parapharyngeal space tumors: surgical approaches in a series of 13 cases. Int J Oral Maxillofac Surg; 2010 Mar;39(3):243-50
MedlinePlus Health Information. consumer health - Throat Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adenocarcinoma / surgery. Adenoma, Pleomorphic / surgery. Adult. Aged. Biopsy, Fine-Needle. Deglutition Disorders / diagnosis. Disease-Free Survival. Female. Follow-Up Studies. Humans. Lip / surgery. Magnetic Resonance Imaging. Male. Mandible / surgery. Middle Aged. Mouth / surgery. Neck / surgery. Osteotomy / classification. Osteotomy / methods. Postoperative Complications. Radiotherapy, Adjuvant. Sarcoma, Synovial / surgery. Tomography, X-Ray Computed. Young Adult

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20005672.001).
  • [ISSN] 1399-0020
  • [Journal-full-title] International journal of oral and maxillofacial surgery
  • [ISO-abbreviation] Int J Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


50. Angiero F, Stefani M: Hyalinizing clear cell carcinoma arising on the anterior palatoglossal arch. Anticancer Res; 2007 Nov-Dec;27(6C):4271-7
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Hyalinizing clear cell carcinoma (HCCC) is very rare in the oral cavity, arising more frequently in the minor salivary glands.
  • This report focuses on the heterogeneous group of clear cell neoplasms with the intent of pointing out some aspects that may contribute to forming a diagnosis of HCCC, and which, above all enable us to distinguish this neoplasm from other very similar forms occurring in the oral cavity.
  • [MeSH-major] Adenocarcinoma, Clear Cell / pathology. Mouth Neoplasms / pathology. Palatal Neoplasms / pathology
  • [MeSH-minor] Biomarkers, Tumor / analysis. Diagnosis, Differential. Female. Humans. Hyalin. Immunohistochemistry. Middle Aged. Palate, Hard / pathology. Palate, Hard / surgery. Salivary Gland Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18214031.001).
  • [ISSN] 0250-7005
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


51. De Ruyck K, de Gelder V, Van Eijkeren M, Boterberg T, De Neve W, Vral A, Thierens H: Chromosomal radiosensitivity in head and neck cancer patients: evidence for genetic predisposition? Br J Cancer; 2008 May 20;98(10):1723-38
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The mean number of radiation-induced chromatid breaks and the proportion of radiosensitive individuals were highest for oral cavity cancer patients (1.26 breaks per cell, 38%) and pharynx cancer patients (1.27 breaks per cell, 35%).
  • In conclusion, enhanced chromosomal radiosensitivity is a marker of genetic predisposition to head and neck cancer, and the genetic contribution is highest for oral cavity and pharynx cancer patients and for early onset and non- and light smoking patients.
  • [MeSH-minor] Adenocarcinoma / genetics. Adult. Age Factors. Aged. Carcinoma, Squamous Cell / genetics. Chromatids / radiation effects. DNA Damage / radiation effects. DNA Repair / radiation effects. DNA, Neoplasm. Female. Genetic Markers. Genetic Predisposition to Disease. Humans. Laryngeal Neoplasms / genetics. Logistic Models. Male. Middle Aged. Mouth Neoplasms / genetics. Odds Ratio. Pharyngeal Neoplasms / genetics. Risk Factors

  • Genetic Alliance. consumer health - Hereditary Cancer.
  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Smoking.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Radiat Biol. 2002 May;78(5):341-6 [12020425.001]
  • [Cites] Int J Radiat Biol. 2002 Apr;78(4):249-57 [12020436.001]
  • [Cites] Int J Radiat Biol. 2002 Sep;78(9):863-6 [12428927.001]
  • [Cites] Br J Cancer. 2002 Dec 2;87(12):1379-85 [12454765.001]
  • [Cites] Toxicol Lett. 2004 Apr 1;149(1-3):345-52 [15093280.001]
  • [Cites] Head Neck. 1989 Jul-Aug;11(4):337-42 [2473966.001]
  • [Cites] JAMA. 1989 Dec 15;262(23):3313-5 [2479781.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 1993 Mar-Apr;2(2):103-6 [7682127.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 1993 Jul-Aug;2(4):329-33 [7688625.001]
  • [Cites] Lancet. 1994 Nov 19;344(8934):1444 [7968110.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1995 Feb;121(2):157-60 [7840922.001]
  • [Cites] J Natl Cancer Inst. 1996 Apr 17;88(8):530-5 [8606381.001]
  • [Cites] Br J Cancer. 1996 Jul;74(1):1-5 [8679441.001]
  • [Cites] BMJ. 1996 Sep 21;313(7059):716-21 [8819440.001]
  • [Cites] Int J Cancer. 1997 Sep 26;73(1):20-4 [9334804.001]
  • [Cites] Br J Cancer. 1998 Feb;77(4):614-20 [9484819.001]
  • [Cites] Clin Cancer Res. 1998 Jul;4(7):1773-8 [9676854.001]
  • [Cites] J Natl Cancer Inst. 1998 Sep 16;90(18):1393-9 [9747870.001]
  • [Cites] Int J Radiat Biol. 1999 Jan;75(1):1-10 [9972785.001]
  • [Cites] Am J Hum Genet. 1999 Sep;65(3):784-94 [10441587.001]
  • [Cites] Semin Oncol. 2004 Dec;31(6):726-33 [15599850.001]
  • [Cites] J Radiat Res. 2004 Dec;45(4):535-41 [15635263.001]
  • [Cites] Oncol Rep. 2005 Feb;13(2):347-53 [15643523.001]
  • [Cites] Cancer Res. 2005 Jan 1;65(1):349-57 [15665313.001]
  • [Cites] J Radiat Res. 2005 Mar;46(1):111-6 [15802866.001]
  • [Cites] Int J Radiat Biol. 2005 May;81(5):373-8 [16076752.001]
  • [Cites] J Exp Clin Cancer Res. 2005 Jun;24(2):217-22 [16110754.001]
  • [Cites] Mutagenesis. 2005 Sep;20(5):381-5 [16105906.001]
  • [Cites] Cancer Res. 2005 Oct 15;65(20):9566-73 [16230422.001]
  • [Cites] Cancer Res. 2005 Dec 15;65(24):11292-6 [16357135.001]
  • [Cites] Br J Cancer. 2006 Apr 24;94(8):1194-203 [16538220.001]
  • [Cites] Mutagenesis. 2006 Sep;21(5):313-20 [16928695.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4):1245-52 [17145539.001]
  • [Cites] Radiother Oncol. 2006 Dec;81(3):257-63 [17113667.001]
  • [Cites] Int J Radiat Biol. 2007 Jan;83(1):1-12 [17357435.001]
  • [Cites] Int J Cancer. 2007 Dec 15;121(12):2735-40 [17724733.001]
  • [Cites] Int J Cancer. 1995 Dec 11;63(6):769-73 [8847131.001]
  • [Cites] Int J Radiat Biol. 2000 May;76(5):607-15 [10866282.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2001 Feb 1;49(2):533-7 [11173151.001]
  • [Cites] Br J Cancer. 2001 Mar 23;84(6):776-82 [11259091.001]
  • [Cites] Br J Cancer. 2001 Apr 6;84(7):892-6 [11286467.001]
  • [Cites] Br J Cancer. 2001 Oct 19;85(8):1157-61 [11710829.001]
  • [Cites] Acta Oncol. 2001;40(6):702-11 [11765064.001]
  • [Cites] Curr Opin Oncol. 2002 May;14(3):310-7 [11981277.001]
  • [Cites] Cancer. 2002 Aug 1;95(3):563-8 [12209748.001]
  • (PMID = 18414410.001).
  • [ISSN] 1532-1827
  • [Journal-full-title] British journal of cancer
  • [ISO-abbreviation] Br. J. Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / DNA, Neoplasm; 0 / Genetic Markers
  • [Other-IDs] NLM/ PMC2391130
  •  go-up   go-down


52. Momm F, Volegova-Neher NJ, Schulte-Mönting J, Guttenberger R: Different saliva substitutes for treatment of xerostomia following radiotherapy. A prospective crossover study. Strahlenther Onkol; 2005 Apr;181(4):231-6
MedlinePlus Health Information. consumer health - Radiation Therapy.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This will help to find the individually best way to cope with the dry mouth.
  • [MeSH-minor] Adenocarcinoma / radiotherapy. Adult. Aged. Aged, 80 and over. Carcinoma, Squamous Cell / radiography. Choice Behavior. Cross-Over Studies. Female. Humans. Lymphoma / radiotherapy. Male. Middle Aged. Radiotherapy Dosage. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15827692.001).
  • [ISSN] 0179-7158
  • [Journal-full-title] Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]
  • [ISO-abbreviation] Strahlenther Onkol
  • [Language] eng
  • [Publication-type] Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Saliva, Artificial
  •  go-up   go-down


53. Bingle L, Cross SS, High AS, Wallace WA, Rassl D, Yuan G, Hellstrom I, Campos MA, Bingle CD: WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung. Respir Res; 2006;7:61
antibodies-online. View related products from antibodies-online.com (subscription/membership/fee required).

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung.
  • CONCLUSION: We believe that these studies support the hypothesis that WFDC2 may be a component of the innate immune defences of the lung, nasal and oral cavities and suggest that WFDC2 functions in concert with related WAP domain containing proteins in epithelial host defence.
  • [MeSH-major] Adenocarcinoma / immunology. Epididymal Secretory Proteins / physiology. Lung Neoplasms / immunology. Mouth / immunology. Proteins / physiology. Respiratory System / immunology

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Gene. 1999 Oct 1;238(2):375-85 [10570965.001]
  • [Cites] Gynecol Oncol. 2005 Nov;99(2):267-77 [16061277.001]
  • [Cites] J Biol Chem. 2000 Jul 21;275(29):22136-46 [10766760.001]
  • [Cites] Biochim Biophys Acta. 2000 Oct 2;1493(3):363-7 [11018263.001]
  • [Cites] Nat Med. 2000 Oct;6(10):1147-53 [11017147.001]
  • [Cites] Cancer Res. 2000 Nov 15;60(22):6281-7 [11103784.001]
  • [Cites] Am J Respir Cell Mol Biol. 2001 Jul;25(1):84-91 [11472979.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13784-9 [11707590.001]
  • [Cites] Mol Hum Reprod. 2002 Apr;8(4):341-9 [11912282.001]
  • [Cites] Oncogene. 2002 Apr 18;21(17):2768-73 [11965550.001]
  • [Cites] Biochem Soc Trans. 2002 Apr;30(2):98-102 [12023833.001]
  • [Cites] Biochem Soc Trans. 2002 Apr;30(2):116-20 [12023837.001]
  • [Cites] Am J Respir Cell Mol Biol. 2002 Oct;27(4):436-45 [12356577.001]
  • [Cites] Biol Chem. 2002 Jul-Aug;383(7-8):1249-56 [12437112.001]
  • [Cites] Cancer Res. 2003 Jul 1;63(13):3695-700 [12839961.001]
  • [Cites] Mol Biol Cell. 2003 Nov;14(11):4376-86 [12960427.001]
  • [Cites] Am J Respir Cell Mol Biol. 2004 Feb;30(2):184-92 [12920053.001]
  • [Cites] J Clin Oncol. 2004 Mar 1;22(5):811-9 [14990636.001]
  • [Cites] Clin Cancer Res. 2004 May 15;10(10):3291-300 [15161682.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1982 May-Jun;91(3 Pt 1):268-71 [7046595.001]
  • [Cites] Environ Health Perspect. 1990 Apr;85:71-80 [2384069.001]
  • [Cites] Biol Reprod. 1991 Aug;45(2):350-7 [1686187.001]
  • [Cites] In Vitro Cell Dev Biol Anim. 1993 Jun;29A(6):481-92 [7687243.001]
  • [Cites] Biochem J. 1996 Jun 15;316 ( Pt 3):967-75 [8670177.001]
  • [Cites] Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):1092-8 [8887613.001]
  • [Cites] Infect Immun. 1996 Nov;64(11):4520-4 [8890201.001]
  • [Cites] Cell. 1997 Feb 7;88(3):417-26 [9039268.001]
  • [Cites] Blood. 1997 Aug 1;90(3):1141-9 [9242546.001]
  • [Cites] Am J Respir Crit Care Med. 1997 Oct;156(4 Pt 1):1235-40 [9351627.001]
  • [Cites] Biochem Biophys Res Commun. 1997 Dec 18;241(2):305-11 [9425267.001]
  • [Cites] Gene. 1999 Mar 18;229(1-2):101-8 [10095109.001]
  • [Cites] Biochem J. 1999 Jun 15;340 ( Pt 3):569-77 [10359639.001]
  • [Cites] FEBS Lett. 1999 Jun 11;452(3):309-13 [10386612.001]
  • [Cites] Eur Respir J. 1999 May;13(5):1029-36 [10414400.001]
  • [Cites] Infect Immun. 1999 Sep;67(9):4485-9 [10456890.001]
  • [Cites] J Pathol. 2005 Mar;205(4):491-7 [15685591.001]
  • [Cites] Cancer Res. 2005 Mar 15;65(6):2162-9 [15781627.001]
  • [Cites] Am J Respir Cell Mol Biol. 2005 May;32(5):443-52 [15668324.001]
  • [Cites] Am J Physiol Lung Cell Mol Physiol. 2005 Oct;289(4):L545-53 [15937068.001]
  • [Cites] Mol Cell Proteomics. 2005 Sep;4(9):1251-64 [15951573.001]
  • [Cites] J Mol Graph Model. 1999 Apr;17(2):106-13, 134-6 [10680116.001]
  • (PMID = 16600032.001).
  • [ISSN] 1465-993X
  • [Journal-full-title] Respiratory research
  • [ISO-abbreviation] Respir. Res.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Epididymal Secretory Proteins; 0 / Proteins; 0 / WFDC2 protein, human
  • [Other-IDs] NLM/ PMC1459147
  •  go-up   go-down


54. Salgarelli AC, Cangiano A, Broccaioli EA, Collini M: Temporal myofascial flap in reconstructive surgery of the oral cavity. Minerva Stomatol; 2006 May;55(5):281-7
MedlinePlus Health Information. consumer health - Oral Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Temporal myofascial flap in reconstructive surgery of the oral cavity.
  • [MeSH-major] Carcinoma / surgery. Facial Muscles / surgery. Facial Neoplasms / surgery. Mouth Neoplasms / surgery. Oral Surgical Procedures / methods. Surgical Flaps
  • [MeSH-minor] Adenocarcinoma / surgery. Humans. Maxillary Neoplasms / surgery. Orbit Evisceration. Orbital Neoplasms / surgery. Parotid Neoplasms / surgery. Postoperative Complications. Retrospective Studies. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16688104.001).
  • [ISSN] 0026-4970
  • [Journal-full-title] Minerva stomatologica
  • [ISO-abbreviation] Minerva Stomatol
  • [Language] eng; ita
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


55. Fennessy BG, Sheahan P, Toner M, Timon C: A subcutaneous mandibulotomy approach for a salivary clear cell carcinoma of the retromolar trigone. Ir J Med Sci; 2010 Mar;179(1):147-9
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CONCLUSION: This is the first occasion a subcutaneous mandibulotomy approach for an oral tumour has been described in Great Britain and Ireland, the second reported case of clear cell carcinoma originating in the retromolar trigone region and only the fourth case of associated lymph nodal metastases.
  • [MeSH-major] Adenocarcinoma, Clear Cell / surgery. Mandible / surgery. Mandibular Neoplasms / surgery
  • [MeSH-minor] Adult. Humans. Male. Mouth Neoplasms / pathology. Mouth Neoplasms / surgery. Salivary Gland Neoplasms / pathology. Salivary Gland Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18696176.001).
  • [ISSN] 1863-4362
  • [Journal-full-title] Irish journal of medical science
  • [ISO-abbreviation] Ir J Med Sci
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Ireland
  • [Number-of-references] 8
  •  go-up   go-down


56. O'Sullivan EM: Oral and pharyngeal cancer in Ireland. Ir Med J; 2005 Apr;98(4):102-5
MedlinePlus Health Information. consumer health - Throat Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Oral and pharyngeal cancer in Ireland.
  • Early diagnosis and treatment of cancer are essential to achieving a good prognosis.
  • This is particularly true for oral and pharyngeal cancer (OPC) which accounts for over half a million new cases and 200,000 deaths worldwide per annum.
  • Due to the age and general medical profile of the average oral cancer patient, many attend their general physician on a regular basis.
  • [MeSH-major] Mouth Neoplasms / epidemiology. Pharyngeal Neoplasms / epidemiology
  • [MeSH-minor] Adenocarcinoma / diagnosis. Adenocarcinoma / epidemiology. Adenocarcinoma / etiology. Carcinoma, Squamous Cell / diagnosis. Carcinoma, Squamous Cell / epidemiology. Carcinoma, Squamous Cell / etiology. Female. Humans. Ireland / epidemiology. Lymphoma / diagnosis. Lymphoma / epidemiology. Lymphoma / etiology. Male. Registries

  • Genetic Alliance. consumer health - Oral cancer.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15938551.001).
  • [ISSN] 0332-3102
  • [Journal-full-title] Irish medical journal
  • [ISO-abbreviation] Ir Med J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Ireland
  •  go-up   go-down


57. Mok TS, Lam KC, Lee C, Zhang L, Wong H, Chan AT, Yeo W, Yim AP, Chak K, Zee B: Phase II randomized study comparing the toxicity profile of gemcitabine plus cisplatin with gemcitabine plus oral etoposide in the treatment of advanced non-small cell lung cancer. Oncology; 2005;68(4-6):485-92
Hazardous Substances Data Bank. ETOPOSIDE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Phase II randomized study comparing the toxicity profile of gemcitabine plus cisplatin with gemcitabine plus oral etoposide in the treatment of advanced non-small cell lung cancer.
  • METHODS: Eighty-nine chemotherapy-naïve patients were randomized either to gemcitabine (1,000 mg/m2, 30-min infusion on days 1, 8 and 15) and oral etoposide (50 mg, days 1-14; GE group) or gemcitabine at the same schedule and cisplatin (75 mg/m2 on day 15; GP group).
  • Other symptoms including sore mouth and hair loss were significantly higher in the GE arm (p = 0.003 and 0.007, respectively).
  • [MeSH-minor] Adenocarcinoma / drug therapy. Adenocarcinoma / pathology. Adult. Aged. Carcinoma, Squamous Cell / drug therapy. Carcinoma, Squamous Cell / pathology. Cisplatin / administration & dosage. Deoxycytidine / administration & dosage. Deoxycytidine / analogs & derivatives. Etoposide / administration & dosage. Female. Humans. Male. Middle Aged. Neoplasm Staging. Quality of Life. Survival Rate. Treatment Outcome

  • Genetic Alliance. consumer health - Lung Cancer.
  • Genetic Alliance. consumer health - Non-small cell lung cancer.
  • Genetic Alliance. consumer health - Oral cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2005 S. Karger AG, Basel.
  • (PMID = 16020979.001).
  • [ISSN] 0030-2414
  • [Journal-full-title] Oncology
  • [ISO-abbreviation] Oncology
  • [Language] eng
  • [Publication-type] Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0W860991D6 / Deoxycytidine; 6PLQ3CP4P3 / Etoposide; B76N6SBZ8R / gemcitabine; Q20Q21Q62J / Cisplatin
  •  go-up   go-down


58. Mücke T, Kesting MR, Hohlweg-Majert B, Hölzle F, Wolff KD: The role of bronchoscopy and gastroscopy in intraoral minor salivary gland carcinomas at initial staging. Br J Oral Maxillofac Surg; 2009 Dec;47(8):608-11
MedlinePlus Health Information. consumer health - Salivary Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Data were collected about abnormalities detected during endoscopic screening; a biopsy was taken if reasonable and if the resulting diagnosis influenced the planned treatment.
  • [MeSH-minor] Adenocarcinoma / pathology. Adult. Aged. Aged, 80 and over. Biopsy. Bronchitis / diagnosis. Carcinoma, Adenoid Cystic / pathology. Carcinoma, Mucoepidermoid / pathology. Esophageal Neoplasms / diagnosis. Female. Gastroenteritis / diagnosis. Humans. Lung Neoplasms / diagnosis. Lung Neoplasms / secondary. Male. Mass Screening. Middle Aged. Mouth Mucosa / pathology. Neoplasm Staging. Neoplasms, Multiple Primary / diagnosis. Palate / pathology. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19162382.001).
  • [ISSN] 1532-1940
  • [Journal-full-title] The British journal of oral & maxillofacial surgery
  • [ISO-abbreviation] Br J Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


59. Cebeci AR, Gülşahi A, Kamburoglu K, Orhan BK, Oztaş B: Prevalence and distribution of oral mucosal lesions in an adult Turkish population. Med Oral Patol Oral Cir Bucal; 2009 Jun;14(6):E272-7
MedlinePlus Health Information. consumer health - Mouth Disorders.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prevalence and distribution of oral mucosal lesions in an adult Turkish population.
  • OBJECTIVES: The purpose of this study was to assess the prevalence and distribution of oral mucosal lesions in a Turkish adult population.
  • RESULTS: The overall incidence of oral mucosal changes or lesions was 15.5%.
  • In addition, 3 patients (0.06%) were diagnosed as having squamous cell carcinoma, and 1 patient (0.02%) was diagnosed as having adenocarcinoma.
  • Besides, no relation was found between systemic diseases and oral mucosal lesion occurrence.
  • CONCLUSIONS: This study has provided information about the epidemiologic aspects of oral mucosal lesions that may prove valuable in planning of future oral health studies.
  • [MeSH-major] Mouth Diseases / epidemiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19300376.001).
  • [ISSN] 1698-6946
  • [Journal-full-title] Medicina oral, patología oral y cirugía bucal
  • [ISO-abbreviation] Med Oral Patol Oral Cir Bucal
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


60. Hirota SK, Modolo F, Portela de Albuquerque MA, Lehn CN, Sugaya NN, Machado de Sousa SO, Paraiso Cavalcanti MG: Recurring acinic cell carcinoma of the buccal mucosa: a case report. Quintessence Int; 2007 Apr;38(4):289-94
MedlinePlus Health Information. consumer health - Salivary Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A case of acinic cell adenocarcinoma of the left facial area of 10-years' duration in a 29-year-old man is presented.
  • [MeSH-minor] Adult. Diagnosis, Differential. Humans. Immunoenzyme Techniques. Keratin-7 / analysis. Keratin-8 / analysis. Ki-67 Antigen / analysis. Male. Mouth Mucosa / pathology. Vimentin / analysis

  • Genetic Alliance. consumer health - Acinic Cell Carcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17432783.001).
  • [ISSN] 0033-6572
  • [Journal-full-title] Quintessence international (Berlin, Germany : 1985)
  • [ISO-abbreviation] Quintessence Int
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Keratin-7; 0 / Keratin-8; 0 / Ki-67 Antigen; 0 / Vimentin
  •  go-up   go-down


61. Hashibe M, Morgenstern H, Cui Y, Tashkin DP, Zhang ZF, Cozen W, Mack TM, Greenland S: Marijuana use and the risk of lung and upper aerodigestive tract cancers: results of a population-based case-control study. Cancer Epidemiol Biomarkers Prev; 2006 Oct;15(10):1829-34
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The adjusted odds ratio estimate (and 95% confidence limits) for > or =60 versus 0 joint-years was 1.1 (0.56, 2.1) for oral cancer, 0.84 (0.28, 2.5) for laryngeal cancer, and 0.62 (0.32, 1.2) for lung cancer; the adjusted odds ratio estimate for > or =30 versus 0 joint-years was 0.57 (0.20, 1.6) for pharyngeal cancer, and 0.53 (0.22, 1.3) for esophageal cancer.
  • [MeSH-minor] Adenocarcinoma / epidemiology. Adenocarcinoma / etiology. Adolescent. Adult. Aged. Alcohol Drinking / adverse effects. Carcinoma, Large Cell / epidemiology. Carcinoma, Large Cell / etiology. Carcinoma, Squamous Cell / epidemiology. Carcinoma, Squamous Cell / etiology. Case-Control Studies. Confounding Factors (Epidemiology). Esophageal Neoplasms / epidemiology. Esophageal Neoplasms / etiology. Female. Humans. Incidence. Laryngeal Neoplasms / epidemiology. Laryngeal Neoplasms / etiology. Los Angeles / epidemiology. Male. Middle Aged. Mouth Neoplasms / epidemiology. Mouth Neoplasms / etiology. Pharyngeal Neoplasms / epidemiology. Pharyngeal Neoplasms / etiology. Population Surveillance. Risk Factors. Time Factors

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17035389.001).
  • [ISSN] 1055-9965
  • [Journal-full-title] Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • [ISO-abbreviation] Cancer Epidemiol. Biomarkers Prev.
  • [Language] eng
  • [Grant] United States / NIDA NIH HHS / DA / DA11386; United States / NCI NIH HHS / CA / CA96134; United States / NCI NIH HHS / CA / T32 CA009142; United States / NCI NIH HHS / CA / CA77954; United States / NIEHS NIH HHS / ES / ES011667; United States / NCI NIH HHS / CA / CA90833; United States / NCI NIH HHS / CA / CA09142
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


62. de Oliveira Ribas M, Martins WD, de Sousa MH, de Aguiar Koubik AC, Avila LF, Zanferrari FL, Martins G: Oral and maxillofacial manifestations of familial adenomatous polyposis (Gardner's syndrome): a report of two cases. J Contemp Dent Pract; 2009;10(1):82-90
Genetic Alliance. consumer health - Familial Polyposis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Oral and maxillofacial manifestations of familial adenomatous polyposis (Gardner's syndrome): a report of two cases.
  • AIM: The aim of this case report is to emphasize the importance of an early diagnosis of Gardner's syndrome through the detection of lesions appearing in the oral and maxillofacial area as well as to present two cases of the disease.
  • Early diagnosis and therapy of the disease are critical because polyps have a 100% risk of undergoing malignant transformation.
  • Further investigation revealed a familial adenomatous polyposis (FAP) complicated by adenocarcinoma of the colon.
  • Case 2: A 12-year-old Caucasian girl, who is a niece of the patient described in Case 1, presented with progressive difficulty with mouth opening but no complaints of digestive problems.
  • SUMMARY: Since an early diagnosis is essential and general dental practitioners may be the first healthcare professionals to suspect the diagnosis, it is important for them to be familiar with the features of Gardner's syndrome.
  • [MeSH-major] Gardner Syndrome / complications. Gardner Syndrome / diagnosis. Mandibular Neoplasms / etiology. Maxillary Neoplasms / etiology. Osteoma / etiology
  • [MeSH-minor] Adult. Child. Early Diagnosis. Female. Humans. Male. Nose Neoplasms / etiology. Nose Neoplasms / radiography. Radiography, Panoramic. Scalp. Skin Neoplasms / etiology. Skull Base Neoplasms / etiology. Skull Base Neoplasms / radiography. Tooth, Impacted / etiology

  • Genetic Alliance. consumer health - Familial Adenomatous Polyposis (FAP).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19142260.001).
  • [ISSN] 1526-3711
  • [Journal-full-title] The journal of contemporary dental practice
  • [ISO-abbreviation] J Contemp Dent Pract
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


63. Darling MR, Jackson-Boeters L, Daley TD, Diamandis EP: Human kallikrein 13 expression in salivary gland tumors. Int J Biol Markers; 2006 Apr-Jun;21(2):106-10
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Biomarkers, Tumor. Carcinoma, Adenoid Cystic / metabolism. Gene Expression Regulation, Neoplastic. Kallikreins / biosynthesis. Mouth Mucosa / metabolism. Salivary Gland Neoplasms / genetics
  • [MeSH-minor] Adenocarcinoma / metabolism. Adenoma, Pleomorphic / metabolism. Carcinoma, Mucoepidermoid / metabolism. Humans. Immunohistochemistry. Prognosis. Salivary Glands / metabolism

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16847813.001).
  • [ISSN] 0393-6155
  • [Journal-full-title] The International journal of biological markers
  • [ISO-abbreviation] Int. J. Biol. Markers
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; EC 3.4.21.- / KLK13 protein, human; EC 3.4.21.- / Kallikreins
  •  go-up   go-down


64. Katsanos KH, Christodoulou DK, Kamina S, Maria K, Lambri E, Theodorou S, Tsampoulas K, Vasiliki M, Tsianos EV: Diagnosis and endoscopic treatment of esophago-bronchial fistula due to gastric heterotopy. World J Gastrointest Endosc; 2010 Apr 16;2(4):138-42

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diagnosis and endoscopic treatment of esophago-bronchial fistula due to gastric heterotopy.
  • Heterotopic gastric mucosa patches are congenital gastrointestinal abnormalities and have been reported to occur anywhere along the gastrointestinal tract from mouth to anus.
  • Complications of heterotopic gastric mucosa include dysphagia, upper gastrointestinal bleeding, upper esophageal ring stricture, adenocarcinoma and fistula formation.
  • In this case report we describe the diagnosis and treatment of the first case of esophago-bronchial fistula due to heterotopic gastric mucosa in mid esophagus.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21160729.001).
  • [ISSN] 1948-5190
  • [Journal-full-title] World journal of gastrointestinal endoscopy
  • [ISO-abbreviation] World J Gastrointest Endosc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] China
  • [Other-IDs] NLM/ PMC2999170
  • [Keywords] NOTNLM ; Ectopic gastric mucosa / Esophageal fistula therapy / Esophago-bronchial fistula / Esophagus / Gastric heterotopy / Heterotopic gastric mucosa
  •  go-up   go-down


65. Calleja-Macias IE, Kalantari M, Bernard HU: Cholinergic signaling through nicotinic acetylcholine receptors stimulates the proliferation of cervical cancer cells: an explanation for the molecular role of tobacco smoking in cervical carcinogenesis? Int J Cancer; 2009 Mar 1;124(5):1090-6
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We have analyzed the expression of mRNAs encoding nicotinic acetylcholine receptors (nAChRs) in CaSki, SiHa and HeLa cell lines, which are derived from two squamous and one adenocarcinoma of the cervix, respectively.
  • This indicates that cholinergic signaling under normal physiological conditions and stimulated by nicotine in tobacco users affects epithelial homeostasis and neoplastic progression at the cervix in a way similar to the known effects on epithelia of the mouth, the airways and the lung.

  • Genetic Alliance. consumer health - Cervical cancer.
  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • MedlinePlus Health Information. consumer health - Smoking.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. NICOTINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19048619.001).
  • [ISSN] 1097-0215
  • [Journal-full-title] International journal of cancer
  • [ISO-abbreviation] Int. J. Cancer
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P30 CA062203
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Protein Subunits; 0 / Receptors, Nicotinic; 6M3C89ZY6R / Nicotine
  •  go-up   go-down


66. Shan BE, Fu XM, Hua ZX, Li Q, Liang W, Liu J, Zhang H, Liu G: [Study on mechanism of the anti-tumor activity of Acanthopanax gracilistylus]. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Sep;25(9):825-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Study on mechanism of the anti-tumor activity of Acanthopanax gracilistylus].
  • OBJECTIVE: To study the mechanism of anti-tumor activity of Acanthopanax gracilistylus extract (Age).
  • METHODS: The tumor cells proliferation was detected by using (3H)-TdR incorporation method, and the effects of Age on cell cycle of tumor cells, retinoblastoma (Rb) protein and cyclin-dependent kinases (Cdk) were analyzed by flow cytometry and Western blotting assay, respectively.
  • RESULTS: It was indicated by cytoactivity test in vitro that Age only had effect in inhibiting the proliferation of tumor cells, it couldn't lead to death of cells.
  • Under action of Age, the proliferation of tumor cells was halted at G0/G1 stage of cell cycle, and showed no direct cytotoxic effect by Age.
  • Age could induce lowering of the expression of Rb, Cdk2 and Cdk4, cause halt of tumor cell proliferation.
  • CONCLUSION: The tumor inhibitory effect of Age is realized by way of regulating the activity of cell cycle controlling enzymes to suspend the proliferation of tumor cells.

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16248248.001).
  • [ISSN] 1003-5370
  • [Journal-full-title] Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine
  • [ISO-abbreviation] Zhongguo Zhong Xi Yi Jie He Za Zhi
  • [Language] CHI
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Phytogenic; 0 / Drugs, Chinese Herbal; 0 / Retinoblastoma Protein; EC 2.7.11.22 / Cyclin-Dependent Kinase 2; EC 2.7.11.22 / Cyclin-Dependent Kinase 4
  •  go-up   go-down


67. Kabilova TO, Vladimirova A', Chernolovskaya EL, Vlassov VV: Arrest of cancer cell proliferation by dsRNAs. Ann N Y Acad Sci; 2006 Dec;1091:425-36

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adenocarcinoma / genetics. Adenocarcinoma / pathology. Adenocarcinoma / prevention & control. Cell Line, Tumor. HeLa Cells. Humans. Mouth Neoplasms / genetics. Mouth Neoplasms / pathology. Mouth Neoplasms / prevention & control. Neuroblastoma / genetics. Neuroblastoma / pathology. Neuroblastoma / prevention & control

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17341633.001).
  • [ISSN] 0077-8923
  • [Journal-full-title] Annals of the New York Academy of Sciences
  • [ISO-abbreviation] Ann. N. Y. Acad. Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Growth Inhibitors; 0 / RNA, Double-Stranded; 0 / RNA, Small Interfering
  •  go-up   go-down


68. Canjuga I, Mravak-Stipetić M, Kopić V, Galić J: Oral acanthosis nigricans: case report and comparison with literature reports. Acta Dermatovenerol Croat; 2008;16(2):91-5
MedlinePlus Health Information. consumer health - Mouth Disorders.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Oral acanthosis nigricans: case report and comparison with literature reports.
  • Acanthosis nigricans (AN) is a rare condition which may affect oral cavity.
  • Malignant AN is most often associated with gastric adenocarcinoma but cancers of other sites and types may also occur.
  • Oral lesions occurred after the tumor had been diagnosed, i.e. after third operation for tumor recurrence.
  • The fifth operation for tumor recurrence resulted in slight improvement of oral changes.
  • It is concluded that the severity of oral changes is in correlation with tumor progression.
  • The occurrence of oral lesions may be an indicator of tumor progression.
  • [MeSH-major] Acanthosis Nigricans / etiology. Acanthosis Nigricans / pathology. Carcinoma, Transitional Cell / complications. Mouth Diseases / etiology. Mouth Diseases / pathology. Urinary Bladder Neoplasms / complications

  • Genetic Alliance. consumer health - Acanthosis Nigricans.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18541106.001).
  • [ISSN] 1330-027X
  • [Journal-full-title] Acta dermatovenerologica Croatica : ADC
  • [ISO-abbreviation] Acta Dermatovenerol Croat
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Croatia
  • [Number-of-references] 20
  •  go-up   go-down


69. Nakaichi M, Yunuki T, Okuda M, Une S, Taura Y: Activity of matrix metalloproteinase-2 (MMP-2) in canine oronasal tumors. Res Vet Sci; 2007 Apr;82(2):271-9
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Tissue samples from melanoma and squamous cell carcinoma possessed higher MMP-2 activity, as shown in gelatin zymography, in comparison with acanthomatous epulis and nasal adenocarcinoma.
  • However, the MMP-2/TIMP-2 ratio showed a significantly higher level of the genes in the malignant oral melanoma and squamous cell carcinoma.
  • These results indicate that the MMP-2/TIMP-2 ratio may be of value in evaluating the prognosis in canine oronasal cavity tumors.
  • [MeSH-major] Carcinoma, Squamous Cell / veterinary. Dog Diseases / enzymology. Matrix Metalloproteinase 2 / metabolism. Melanoma / veterinary. Mouth Neoplasms / veterinary. Nose Neoplasms / veterinary

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17011604.001).
  • [ISSN] 0034-5288
  • [Journal-full-title] Research in veterinary science
  • [ISO-abbreviation] Res. Vet. Sci.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / RNA, Messenger; 127497-59-0 / Tissue Inhibitor of Metalloproteinase-2; EC 3.4.24.24 / Matrix Metalloproteinase 2; EC 3.4.24.80 / Matrix Metalloproteinase 14
  •  go-up   go-down


70. Anglesio S, Calamia E, Fiandra C, Giglioli FR, Ragona R, Ricardi U, Ropolo R: Prostate brachytherapy with iodine-125 seeds: radiation protection issues. Tumori; 2005 Jul-Aug;91(4):335-8
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma / radiotherapy. Brachytherapy / methods. Iodine Radioisotopes / adverse effects. Prostatic Neoplasms / radiotherapy. Radiation Injuries / etiology. Radiation Injuries / prevention & control. Radiation Protection / methods
  • [MeSH-minor] Aged. Aged, 80 and over. Gloves, Protective. Humans. Male. Mouth Protectors. Occupational Exposure / prevention & control. Protective Clothing. Radiotherapy Dosage

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16277100.001).
  • [ISSN] 0300-8916
  • [Journal-full-title] Tumori
  • [ISO-abbreviation] Tumori
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Iodine Radioisotopes
  •  go-up   go-down


71. Hausner SH, Abbey CK, Bold RJ, Gagnon MK, Marik J, Marshall JF, Stanecki CE, Sutcliffe JL: Targeted in vivo imaging of integrin alphavbeta6 with an improved radiotracer and its relevance in a pancreatic tumor model. Cancer Res; 2009 Jul 15;69(14):5843-50
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Pancreatic ductal adenocarcinoma is highly metastatic and current preoperative evaluation of resectability using noninvasive imaging has limited success, with most patients having metastases at time of surgery.

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Nucl Med. 2005 Aug;46(8):1333-41 [16085591.001]
  • [Cites] Ann Surg. 2005 Aug;242(2):235-43 [16041214.001]
  • [Cites] J Oral Pathol Med. 2006 Jan;35(1):1-10 [16393247.001]
  • [Cites] Mol Pharm. 2006 Sep-Oct;3(5):472-87 [17009846.001]
  • [Cites] J Nucl Med. 2007 Jan;48 Suppl 1:4S-18S [17204716.001]
  • [Cites] J Nucl Med. 2007 Jan;48 Suppl 1:78S-88S [17204723.001]
  • [Cites] Radiology. 2007 Feb;242(2):360-85 [17255408.001]
  • [Cites] Cancer Res. 2007 Feb 1;67(3):1030-7 [17283135.001]
  • [Cites] J Pathol. 2007 Jul;212(3):316-24 [17503414.001]
  • [Cites] Cancer Res. 2007 Jun 15;67(12):5889-95 [17575158.001]
  • [Cites] Cancer Res. 2007 Aug 15;67(16):7833-40 [17699789.001]
  • [Cites] Cancer Invest. 2007 Oct;25(7):632-46 [18027153.001]
  • [Cites] Cancer Res. 2008 Jan 15;68(2):561-70 [18199553.001]
  • [Cites] Clin Oncol (R Coll Radiol). 2008 Feb;20(1):61-6 [17981018.001]
  • [Cites] Am J Pathol. 2008 May;172(5):1271-86 [18385522.001]
  • [Cites] J Hepatobiliary Pancreat Surg. 2008;15(4):429-35 [18670846.001]
  • [Cites] Clin Cancer Res. 2008 Oct 15;14(20):6351-3 [18927272.001]
  • [Cites] J Nucl Med. 2000 Mar;41(3):429-38 [10716315.001]
  • [Cites] Int J Cancer. 2001 Jun 1;92(5):641-50 [11340566.001]
  • [Cites] Adv Drug Deliv Rev. 2003 Feb 10;55(2):217-50 [12564978.001]
  • [Cites] Nat Rev Drug Discov. 2003 Mar;2(3):214-21 [12612647.001]
  • [Cites] Nat Rev Drug Discov. 2003 May;2(5):347-60 [12750738.001]
  • [Cites] Semin Nucl Med. 2004 Jan;34(1):56-69 [14735459.001]
  • [Cites] Histopathology. 2004 Sep;45(3):226-36 [15330800.001]
  • [Cites] J Biol Chem. 1990 Jul 15;265(20):11502-7 [2365683.001]
  • [Cites] Radiology. 1993 Dec;189(3):847-50 [8234714.001]
  • [Cites] J Histochem Cytochem. 1993 Oct;41(10):1521-7 [8245410.001]
  • [Cites] J Cell Sci. 1995 Jun;108 ( Pt 6):2241-51 [7673344.001]
  • [Cites] AJR Am J Roentgenol. 1998 Dec;171(6):1565-70 [9843289.001]
  • [Cites] Ann Surg. 1999 May;229(5):729-37; discussion 737-8 [10235532.001]
  • [Cites] J Clin Invest. 2005 Feb;115(2):339-47 [15668738.001]
  • [Cites] J Hepatobiliary Pancreat Surg. 2004;11(1):4-10 [15747028.001]
  • [Cites] Cancer Metastasis Rev. 2005 Sep;24(3):395-402 [16258727.001]
  • (PMID = 19549907.001).
  • [ISSN] 1538-7445
  • [Journal-full-title] Cancer research
  • [ISO-abbreviation] Cancer Res.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA107792-02; United States / NCI NIH HHS / CA / R21 CA107792; United States / NCI NIH HHS / CA / R21 CA107792-02
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / Benzoates; 0 / Fluorine Radioisotopes; 0 / Integrins; 0 / Radiopharmaceuticals; 0 / Viral Proteins; 0 / integrin alphavbeta6; V5ROO2HOU4 / 4-fluorobenzoic acid
  • [Other-IDs] NLM/ NIHMS117292; NLM/ PMC2711989
  •  go-up   go-down


72. Iezzi G, Piattelli A, Rubini C, Goteri G, Artese L, Perrotti V, Carinci F: Maspin expression in oral squamous cell carcinoma. J Craniofac Surg; 2007 Sep;18(5):1039-43
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Maspin expression in oral squamous cell carcinoma.
  • In contrast, some studies have shown that maspin overexpression is correlated with a poor prognosis in pancreatic and ovarian cancers and in lung adenocarcinoma.
  • The aim of this study was an immunohistochemical evaluation of the maspin expression in oral squamous cell carcinoma and thus 89 patients were evaluated.
  • Maspin expression in oral squamous cell carcinoma was significantly associated with the tumor differentiation grade (chi test: P = 0.0318) and the lymph node status (chi test: P < 0.005), but not with the tumor stage (chi test: P = 0.666).
  • The present results confirm that maspin expression predicts a better prognosis in oral squamous cell carcinoma and that maspin probably plays a role in tumor progression.
  • [MeSH-major] Carcinoma, Squamous Cell / metabolism. Mouth Neoplasms / metabolism. Neoplasm Proteins / metabolism. Serpins / metabolism

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • Genetic Alliance. consumer health - Oral squamous cell carcinoma.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17912078.001).
  • [ISSN] 1049-2275
  • [Journal-full-title] The Journal of craniofacial surgery
  • [ISO-abbreviation] J Craniofac Surg
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Neoplasm Proteins; 0 / SERPIN-B5; 0 / Serpins
  •  go-up   go-down


73. Boffetta P, Aagnes B, Weiderpass E, Andersen A: Smokeless tobacco use and risk of cancer of the pancreas and other organs. Int J Cancer; 2005 May 10;114(6):992-5
MedlinePlus Health Information. consumer health - Smokeless Tobacco.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Limited data are available on the carcinogenicity of smokeless tobacco products in organs other than the mouth.
  • The relative risk of pancreatic cancer for snus use was 1.67 (95% confidence interval [CI] = 1.12, 2.50); that of oral and pharyngeal cancer was 1.10 (95% CI = 0.50, 2.41), that of esophageal cancer was 1.40 (95% CI = 0.61, 3.24), and that of stomach cancer was 1.11 (95% CI = 0.83, 1.48).
  • The relative risks of cancers of the lung (either all histological types or adenocarcinoma), urinary bladder and kidney were not increased among snus users.

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Int J Cancer. 2006 Mar 15;118(6):1582-3; author reply 1586-7 [16206261.001]
  • [CommentIn] Int J Cancer. 2006 Mar 15;118(6):1581; author reply 1586-7 [16206260.001]
  • [CommentIn] Int J Cancer. 2006 Mar 15;118(6):1585; author reply 1586-7 [16206262.001]
  • [CommentIn] Int J Cancer. 2006 Mar 15;118(6):1584; author reply 1586-7 [16206290.001]
  • (PMID = 15645430.001).
  • [ISSN] 0020-7136
  • [Journal-full-title] International journal of cancer
  • [ISO-abbreviation] Int. J. Cancer
  • [Language] eng
  • [Grant] United States / PHPPO CDC HHS / PH / PH 43-64-499
  • [Publication-type] Journal Article; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Carcinogens; 0 / Nitrosamines
  •  go-up   go-down


74. Epelbaum R, Schaffer M, Vizel B, Badmaev V, Bar-Sela G: Curcumin and gemcitabine in patients with advanced pancreatic cancer. Nutr Cancer; 2010;62(8):1137-41
Hazardous Substances Data Bank. CURCUMIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Seventeen patients were enrolled in the study and received 8,000 mg of curcumin by mouth daily, concurrently with gemcitabine 1,000 mg/m(2) IV weekly × 3 of 4 wk; 5 patients (29%) discontinued curcumin after a few days to 2 wk due to intractable abdominal fullness or pain, and the dose of curcumin was reduced to 4,000 mg/day because of abdominal complaints in 2 other patients.
  • Low compliance for curcumin at a dose of 8,000 mg/day, when taken together with systemic gemcitabine, may prevent the use of high doses of oral curcumin needed to achieve systemic effect.
  • [MeSH-minor] Adenocarcinoma / drug therapy. Aged. Disease Progression. Feasibility Studies. Female. Humans. Male. Medication Adherence. Middle Aged. Severity of Illness Index. Survival Analysis

  • Genetic Alliance. consumer health - Pancreatic cancer.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21058202.001).
  • [ISSN] 1532-7914
  • [Journal-full-title] Nutrition and cancer
  • [ISO-abbreviation] Nutr Cancer
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase II; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0 / Antineoplastic Agents, Phytogenic; 0 / bisdesmethoxycurcumin; 0 / desmethoxycurcumin; 0W860991D6 / Deoxycytidine; B76N6SBZ8R / gemcitabine; IT942ZTH98 / Curcumin
  •  go-up   go-down


75. Ajayi OF, Adeyemo WL, Ladeinde AL, Ogunlewe MO, Omitola OG, Effiom OA, Arotiba GT: Malignant orofacial neoplasms in children and adolescents: a clinicopathologic review of cases in a Nigerian tertiary hospital. Int J Pediatr Otorhinolaryngol; 2007 Jun;71(6):959-63
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: A retrospective review of malignant orofacial tumours in children and adolescents <or=19 years from January 1992 to December 2003 from the records of the Department of Oral Pathology and Biology of the Lagos University Teaching Hospital, Nigeria was carried out.
  • [MeSH-major] Facial Neoplasms / epidemiology. Mouth Neoplasms / epidemiology
  • [MeSH-minor] Adenocarcinoma / epidemiology. Adolescent. Adult. Age Factors. Burkitt Lymphoma / epidemiology. Carcinoma / epidemiology. Child. Child, Preschool. Female. Humans. Lymphoma / epidemiology. Male. Nigeria / epidemiology. Osteosarcoma / epidemiology. Retrospective Studies. Rhabdomyosarcoma / epidemiology. Sarcoma / epidemiology. Sex Factors

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17418424.001).
  • [ISSN] 0165-5876
  • [Journal-full-title] International journal of pediatric otorhinolaryngology
  • [ISO-abbreviation] Int. J. Pediatr. Otorhinolaryngol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Ireland
  •  go-up   go-down


76. Murakami J, Lee YJ, Kokeguchi S, Tsujigiwa H, Asaumi J, Nagatsuka H, Fukui K, Kuroda M, Tanaka N, Matsubara N: Depletion of O6-methylguanine-DNA methyltransferase by O6-benzylguanine enhances 5-FU cytotoxicity in colon and oral cancer cell lines. Oncol Rep; 2007 Jun;17(6):1461-7
Hazardous Substances Data Bank. GUANINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Depletion of O6-methylguanine-DNA methyltransferase by O6-benzylguanine enhances 5-FU cytotoxicity in colon and oral cancer cell lines.
  • Therefore, we sought to investigate the relationship between the expression levels of MGMT and the anti-tumor effect of 5-FU in vitro by using two colon adenocarcinoma and four oral cancer cell lines with a variety of MGMT expression.
  • [MeSH-major] Antineoplastic Agents / pharmacology. Colonic Neoplasms / enzymology. Enzyme Inhibitors / pharmacology. Fluorouracil / pharmacology. Guanine / analogs & derivatives. Mouth Neoplasms / enzymology. O(6)-Methylguanine-DNA Methyltransferase / antagonists & inhibitors

  • Genetic Alliance. consumer health - Oral cancer.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17487405.001).
  • [ISSN] 1021-335X
  • [Journal-full-title] Oncology reports
  • [ISO-abbreviation] Oncol. Rep.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Enzyme Inhibitors; 19916-73-5 / O(6)-benzylguanine; 5Z93L87A1R / Guanine; EC 2.1.1.63 / O(6)-Methylguanine-DNA Methyltransferase; U3P01618RT / Fluorouracil
  •  go-up   go-down


77. Zhang W, Feng S, Yan S, Zhao Y, Li M, Sun J, Zhang FC, Cui Q, Dong Y: Incidence of malignancy in primary Sjogren's syndrome in a Chinese cohort. Rheumatology (Oxford); 2010 Mar;49(3):571-7
MedlinePlus Health Information. consumer health - Sjogren's Syndrome.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Different types of malignancy were observed including eight lymphomas, two myeloid myelomas and 19 solid tumours, which consisted of invasive thymoma, breast cancer, lung cancer, gastrointestinal adenocarcinoma, hepatoma, squamous cell carcinoma of tongue, uterine cervix cancer, renal carcinoma, thyroid carcinoma and mucoepidermoid carcinoma of parotid gland.
  • Associations between pSS and other malignant tumours such as myeloid myeloma, mouth cancer, breast cancer and thymoma need to be further observed.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20040528.001).
  • [ISSN] 1462-0332
  • [Journal-full-title] Rheumatology (Oxford, England)
  • [ISO-abbreviation] Rheumatology (Oxford)
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


78. Jeon WJ, You IY, Chae HB, Park SM, Youn SJ: A new technique for gastric endoscopic submucosal dissection: peroral traction-assisted endoscopic submucosal dissection. Gastrointest Endosc; 2009 Jan;69(1):29-33
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • After that, one hemostatic clip, tied by using a white silk suture, was applied at a site of the lesion suitable for oral traction.
  • During submucosal dissection, the applied suture material was pulled to the oral side.
  • [MeSH-major] Adenocarcinoma / surgery. Adenoma / surgery. Gastric Mucosa / pathology. Gastroscopy / methods. Stomach Neoplasms / surgery
  • [MeSH-minor] Aged. Biopsy, Needle. Dissection / methods. Female. Gastroscopes. Humans. Immunohistochemistry. Male. Middle Aged. Minimally Invasive Surgical Procedures / methods. Mouth. Neoplasm Staging. Prognosis. Risk Assessment. Sampling Studies. Sensitivity and Specificity. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19111686.001).
  • [ISSN] 1097-6779
  • [Journal-full-title] Gastrointestinal endoscopy
  • [ISO-abbreviation] Gastrointest. Endosc.
  • [Language] eng
  • [Publication-type] Comparative Study; Evaluation Studies; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


79. Perez L, Shurin MR, Collins B, Kogan D, Tourkova IL, Shurin GV: Comparative analysis of CD1a, S-100, CD83, and CD11c human dendritic cells in normal, premalignant, and malignant tissues. Histol Histopathol; 2005 10;20(4):1165-72

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Normal human lung, oral epithelial hyperplasia lesions, oral squamous cell carcinoma, and prostate adenocarcinoma tissues were evaluated using a panel of DC specific antibodies.
  • [MeSH-minor] Biomarkers. Humans. Hyperplasia. Immunohistochemistry. Lung / immunology. Lung / metabolism. Mouth Mucosa / immunology. Mouth Mucosa / metabolism. Mouth Mucosa / pathology. Spleen / immunology. Spleen / metabolism. Spleen / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16136499.001).
  • [ISSN] 0213-3911
  • [Journal-full-title] Histology and histopathology
  • [ISO-abbreviation] Histol. Histopathol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / R01 CA80126; United States / NCI NIH HHS / CA / R01 CA84270
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] Spain
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Antigens, CD1; 0 / Antigens, CD11c; 0 / Biomarkers; 0 / CD1a antigen; 0 / CD83 antigen; 0 / Immunoglobulins; 0 / Membrane Glycoproteins; 0 / S100 Proteins
  •  go-up   go-down


80. Giri S, Poindexter KM, Sundar SN, Firestone GL: Arecoline induced disruption of expression and localization of the tight junctional protein ZO-1 is dependent on the HER 2 expression in human endometrial Ishikawa cells. BMC Cell Biol; 2010 Jul 06;11:53
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Approximately 600 million people chew Betel nut, making this practice the fourth most popular oral habit in the world.
  • Arecoline, the major alkaloid present in betel nut is one of the causative agents for precancerous lesions and several cancers of mouth among those who chew betel nut.
  • However, few reports exist as to the effects of arecoline in human tissues other than oral cancer cell lines.
  • CONCLUSION: Arecoline is known to induce precancerous lesions and cancer in the oral cavity of betel nut users.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. DEXAMETHASONE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Biol Cell. 2000 Mar;11(3):849-62 [10712504.001]
  • [Cites] Biochem Pharmacol. 2007 Feb 15;73(4):561-73 [17123469.001]
  • [Cites] Oral Oncol. 2001 Sep;37(6):477-92 [11435174.001]
  • [Cites] Carcinogenesis. 2001 Sep;22(9):1527-35 [11532876.001]
  • [Cites] Rapid Commun Mass Spectrom. 2003;17(17):1958-64 [12913859.001]
  • [Cites] Br J Psychiatry. 1981 Jan;138:46-50 [7023592.001]
  • [Cites] Science. 1985 Dec 6;230(4730):1132-9 [2999974.001]
  • [Cites] Nature. 1986 Jan 16-22;319(6050):230-4 [3003577.001]
  • [Cites] Science. 1987 Jan 9;235(4785):177-82 [3798106.001]
  • [Cites] Cold Spring Harb Symp Quant Biol. 1986;51 Pt 2:977-82 [3472771.001]
  • [Cites] Mol Cell Biol. 1987 May;7(5):2019-23 [3299059.001]
  • [Cites] Oncogene. 1988 Mar;2(3):283-7 [3281095.001]
  • [Cites] Science. 1989 May 12;244(4905):707-12 [2470152.001]
  • [Cites] Cancer Res. 1989 Sep 15;49(18):4968-71 [2569928.001]
  • [Cites] Virchows Arch B Cell Pathol Incl Mol Pathol. 1989;57(5):285-90 [2570489.001]
  • [Cites] Cancer Res. 1990 Jan 15;50(2):421-5 [1967224.001]
  • [Cites] Obstet Gynecol. 1990 Sep;76(3 Pt 1):381-7 [1974342.001]
  • [Cites] Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3460-4 [2014265.001]
  • [Cites] Cancer Res. 1991 Jun 15;51(12):3296-303 [1674898.001]
  • [Cites] Cancer Lett. 1992 Aug 31;65(3):215-20 [1355405.001]
  • [Cites] J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):21-5 [1356014.001]
  • [Cites] J Urol. 1993 Nov;150(5 Pt 1):1427-33 [8105108.001]
  • [Cites] J Biol Chem. 1994 May 20;269(20):14661-5 [7514177.001]
  • [Cites] Biochim Biophys Acta. 1994 Dec 30;1198(2-3):165-84 [7819273.001]
  • [Cites] Breast Cancer Res Treat. 1994;31(2-3):325-35 [7881109.001]
  • [Cites] Hum Pathol. 1995 Jun;26(6):601-6 [7774888.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10779-84 [8855257.001]
  • [Cites] Life Sci. 1997;61(11):1083-95 [9307054.001]
  • [Cites] J Cell Biol. 1997 Nov 3;139(3):785-95 [9348294.001]
  • [Cites] Biochim Biophys Acta. 1998 Feb 20;1377(1):M25-37 [9540810.001]
  • [Cites] Clin Cancer Res. 1997 Jan;3(1):3-9 [9815530.001]
  • [Cites] Am J Pathol. 1998 Dec;153(6):1767-73 [9846967.001]
  • [Cites] Public Health. 1999 Jul;113(4):189-92 [10483082.001]
  • [Cites] Clin Oral Investig. 1999 Mar;3(1):25-9 [10522189.001]
  • [Cites] Cell Res. 2005 Jul;15(7):504-10 [16045813.001]
  • [Cites] Mol Endocrinol. 2007 Oct;21(10):2403-15 [17595317.001]
  • [Cites] Oral Oncol. 2008 Feb;44(2):180-6 [17418620.001]
  • [Cites] Drug Alcohol Depend. 2008 May 1;95(1-2):134-9 [18282667.001]
  • [Cites] J Formos Med Assoc. 2008 May;107(5):355-63 [18492619.001]
  • [Cites] Histochem Cell Biol. 2008 Jul;130(1):1-20 [18365233.001]
  • [Cites] Oral Oncol. 2008 Sep;44(9):884-90 [18234541.001]
  • [Cites] Bull World Health Organ. 2005 Sep;83(9):656-60 [16211156.001]
  • [Cites] Chem Res Toxicol. 2006 Jun;19(6):818-27 [16780361.001]
  • [Cites] Toxicology. 2006 Oct 3;227(1-2):94-104 [16945459.001]
  • [Cites] EMBO J. 2000 May 2;19(9):2024-33 [10790369.001]
  • (PMID = 20604955.001).
  • [ISSN] 1471-2121
  • [Journal-full-title] BMC cell biology
  • [ISO-abbreviation] BMC Cell Biol.
  • [Language] ENG
  • [Grant] United States / NIDDK NIH HHS / DK / DK042799-21; United States / NIDDK NIH HHS / DK / R01 DK042799; United States / NIDDK NIH HHS / DK / DK-42799; United States / NIDDK NIH HHS / DK / R01 DK042799-21
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Membrane Proteins; 0 / Phosphoproteins; 0 / TJP1 protein, human; 0 / Zonula Occludens-1 Protein; 4ALN5933BH / Arecoline; 7S5I7G3JQL / Dexamethasone; EC 2.7.10.1 / ERBB2 protein, human; EC 2.7.10.1 / Receptor, ErbB-2
  • [Other-IDs] NLM/ PMC2910664
  •  go-up   go-down


81. Kleikamp S, Böhm M, Frosch P, Brinkmeier T: [Acanthosis nigricans, papillomatosis mucosae and "tripe palms" in a patient with metastasized gastric carcinoma]. Dtsch Med Wochenschr; 2006 May 26;131(21):1209-13
MedlinePlus Health Information. consumer health - Stomach Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • HISTORY AND CLINICAL FINDINGS: A 48-year-old obese man presented with thickening, coarseness and hyperpigmentation of the skin, especially of the intertriginous areas, papillomatous to verrucous lesions of the lips and buccal oral mucosa, and hyperkeratosis of the palms ("tripe palms") and soles.
  • Gastroscopic findings were suspicious of adenocarcinoma of the stomach: it was classified histologically as a signet-ring cell, non-mucinous adenocarcinoma.
  • At the time of diagnosis the tumor had already metastasized to perigastric and peripancreatic lymph nodes with peritoneal carcinosis.
  • [MeSH-major] Carcinoma, Signet Ring Cell / diagnosis. Carcinoma, Signet Ring Cell / secondary. Skin Diseases / etiology. Stomach Neoplasms / diagnosis. Stomach Neoplasms / pathology
  • [MeSH-minor] Acanthosis Nigricans / diagnosis. Acanthosis Nigricans / etiology. Antigens, Tumor-Associated, Carbohydrate / blood. Biomarkers, Tumor / blood. CA-19-9 Antigen / blood. Carcinoembryonic Antigen / blood. Fatal Outcome. Humans. Immunohistochemistry. Keratoderma, Palmoplantar / diagnosis. Keratoderma, Palmoplantar / etiology. Lymphatic Metastasis. Male. Middle Aged. Mouth Neoplasms / diagnosis. Mouth Neoplasms / etiology. Obesity / complications. Papilloma / diagnosis. Papilloma / etiology. Peritoneal Neoplasms / secondary. Receptor, Melanocortin, Type 1 / analysis

  • Genetic Alliance. consumer health - Acanthosis Nigricans.
  • MedlinePlus Health Information. consumer health - Skin Conditions.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16721709.001).
  • [ISSN] 0012-0472
  • [Journal-full-title] Deutsche medizinische Wochenschrift (1946)
  • [ISO-abbreviation] Dtsch. Med. Wochenschr.
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antigens, Tumor-Associated, Carbohydrate; 0 / Biomarkers, Tumor; 0 / CA-19-9 Antigen; 0 / CA-72-4 antigen; 0 / Carcinoembryonic Antigen; 0 / Receptor, Melanocortin, Type 1
  •  go-up   go-down


82. Ruiz-Tovar J, Martín-Pérez E, Gamallo-Amat C: Distal cholangiocarcinoma associated with papillitis with viral CMV inclusions. Dig Surg; 2005;22(6):464-6
MedlinePlus Health Information. consumer health - Cytomegalovirus Infections.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Numerous reports show that CMV is a potential pathogen in the gastrointestinal tract, even in immunocompetent patients, where it can produce lesions from the mouth to the anus.
  • Histological analysis revealed moderately differentiated ductal adenocarcinoma of the distal bile tract.

  • MedlinePlus Health Information. consumer health - Bile Duct Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2005 S. Karger AG, Basel.
  • (PMID = 16549927.001).
  • [ISSN] 0253-4886
  • [Journal-full-title] Digestive surgery
  • [ISO-abbreviation] Dig Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


83. Francisco JS, Alfaro SE, Oliveira DC, Tonon S, Dias EP: Apocrine carcinoma in the parotid gland and in the submandibular region. Braz J Otorhinolaryngol; 2005 Mar-Apr;71(2):224-7
MedlinePlus Health Information. consumer health - Oral Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The objectives of this paper are to report a case of apocrine carcinoma and the discussion of aspects related to its diagnosis, treatment, and prognosis.
  • Carcinomas with apocrine differentiation not related to extramammary Paget's disease, ductal breast carcinoma, Moll's glands adenocarcinoma and ceruminous glands carcinoma are very uncommon tumors.
  • [MeSH-major] Apocrine Glands. Carcinoma / pathology. Mouth Neoplasms / pathology. Sweat Gland Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16446921.001).
  • [ISSN] 1808-8694
  • [Journal-full-title] Brazilian journal of otorhinolaryngology
  • [ISO-abbreviation] Braz J Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


84. Pires FR, Azevedo RS, Ficarra G, Cardoso AS, Carlos R, Kowalski LP, de Almeida OP: Metastatic renal cell carcinoma to the oral cavity and clear cell mucoepidermoid carcinoma: comparative clinicopathologic and immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Apr;109(4):e22-7
Hazardous Substances Data Bank. Carminic acid .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastatic renal cell carcinoma to the oral cavity and clear cell mucoepidermoid carcinoma: comparative clinicopathologic and immunohistochemical study.
  • BACKGROUND: Metastatic clear cell renal cell carcinoma (CCRCC) should be considered in differential diagnosis of intraoral clear cell tumors, including mucoepidermoid carcinoma (MEC).
  • OBJECTIVE AND STUDY DESIGN: We compared the clinical, histologic, histochemical, and immunohistochemical characteristics of 9 oral metastatic CCRCCs and 8 intraoral clear cell MECs.
  • RESULTS: Oral metastatic CCRCC affected salivary-gland containing tissues in 7 cases (78%).
  • Microscopically, oral metastasis revealed a proliferation of neoplastic clear cells arranged in an alveolar pattern with central blood vessels, features that were not seen in any intraoral clear cell MEC.
  • Immunohistochemistry showed similarities in cytokeratin expression; vimentin and CD10 were expressed in all oral metastatic CCRCCs but in only 1 clear cell MEC each.
  • CONCLUSIONS: Besides clinical history, the alveolar pattern, vessel distribution, absence of mucicarmine staining, and vimentin and CD10 immunoexpression are useful in histologic differential diagnosis of CCRCC and clear cell MEC.
  • [MeSH-major] Adenocarcinoma, Clear Cell / secondary. Carcinoma, Mucoepidermoid / diagnosis. Carcinoma, Renal Cell / secondary. Mouth Neoplasms / secondary
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Carmine. Cell Nucleus / ultrastructure. Coloring Agents. Cytoplasm / ultrastructure. Diagnosis, Differential. Female. Hemorrhage / pathology. Histocytochemistry. Humans. Immunohistochemistry. Keratins / analysis. Male. Microvessels / pathology. Middle Aged. Neprilysin / analysis. Salivary Gland Neoplasms / blood supply. Salivary Gland Neoplasms / pathology. Salivary Gland Neoplasms / secondary. Vimentin / analysis

  • Genetic Alliance. consumer health - Clear Cell Renal Cell Carcinoma.
  • Genetic Alliance. consumer health - Mucoepidermoid carcinoma.
  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Mosby, Inc. All rights reserved.
  • (PMID = 20303042.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Coloring Agents; 0 / Vimentin; 51395-97-2 / mucicarmine; 68238-35-7 / Keratins; CID8Z8N95N / Carmine; EC 3.4.24.11 / Neprilysin
  •  go-up   go-down


85. Ariyoshi Y, Miyatake S, Kimura Y, Shimahara T, Kawabata S, Nagata K, Suzuki M, Maruhashi A, Ono K, Shimahara M: Boron neuron capture therapy using epithermal neutrons for recurrent cancer in the oral cavity and cervical lymph node metastasis. Oncol Rep; 2007 Oct;18(4):861-6
Hazardous Substances Data Bank. BORON COMPOUNDS .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Boron neuron capture therapy using epithermal neutrons for recurrent cancer in the oral cavity and cervical lymph node metastasis.
  • The purpose of this clinical trial was to evaluate the utility of boron neutron capture therapy (BNCT) using epithermal neutrons for cases of recurrent cancer in the oral cavity, which are not indicated for a conventional treatment modality.
  • Mild malaise, oral mucositis and alopecia were seen as mild adverse effects; however, no life-threatening systemic symptoms were observed in any of the cases.
  • Our results suggested that BNCT is a useful treatment modality for recurrent or regionally metastasized oral cancer.
  • [MeSH-major] Boron Neutron Capture Therapy / methods. Mouth Neoplasms / radiotherapy. Neoplasm Recurrence, Local / radiotherapy. Neutrons
  • [MeSH-minor] Adenocarcinoma / radiotherapy. Adult. Aged. Boron Compounds / therapeutic use. Carcinoma, Mucoepidermoid / radiotherapy. Carcinoma, Squamous Cell / radiotherapy. Female. Head and Neck Neoplasms / radiotherapy. Humans. Lymphatic Metastasis / radiotherapy. Magnetic Resonance Imaging. Male. Middle Aged. Positron-Emission Tomography. Tomography, X-Ray Computed. Treatment Outcome

  • Genetic Alliance. consumer health - Oral cancer.
  • Genetic Alliance. consumer health - Cervical cancer.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17786347.001).
  • [ISSN] 1021-335X
  • [Journal-full-title] Oncology reports
  • [ISO-abbreviation] Oncol. Rep.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Boron Compounds
  •  go-up   go-down


86. Antunes AA, Antunes AP: Gnathic bone metastasis: a retrospective study of 10 cases. Braz J Otorhinolaryngol; 2008 Jul-Aug;74(4):561-5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Oral cavity metastases are extremely rare, and comprise 1% of all mouth malignant neoplasms.
  • The thyroid and prostate glands were the most prevalent primary tumor sites for metastases (03 cases each); the adenocarcinoma histological type had the highest metastatic rate (50%).
  • The thyroid and prostate seem to be the most frequent sites of distance metastasis of the jaws; the adenocarcinoma is the most frequent histological type causing such metastases.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18852982.001).
  • [ISSN] 1808-8694
  • [Journal-full-title] Brazilian journal of otorhinolaryngology
  • [ISO-abbreviation] Braz J Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


87. Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL, Ng CS, Badmaev V, Kurzrock R: Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res; 2008 Jul 15;14(14):4491-9
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • EXPERIMENTAL DESIGN: Patients received 8 g curcumin by mouth daily until disease progression, with restaging every 2 months.
  • Circulating curcumin was detectable as drug in glucuronide and sulfate conjugate forms, albeit at low steady-state levels, suggesting poor oral bioavailability.
  • CONCLUSIONS: Oral curcumin is well tolerated and, despite its limited absorption, has biological activity in some patients with pancreatic cancer.
  • [MeSH-major] Adenocarcinoma / drug therapy. Antineoplastic Agents / therapeutic use. Curcumin / therapeutic use. Pancreatic Neoplasms / drug therapy

  • Genetic Alliance. consumer health - Pancreatic cancer.
  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CURCUMIN .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Clin Cancer Res. 2009 Jan 15;15(2):747; author reply 747 [19147784.001]
  • [CommentIn] Clin Cancer Res. 2009 Nov 15;15(22):7108; author reply 7108-9 [19903776.001]
  • (PMID = 18628464.001).
  • [ISSN] 1078-0432
  • [Journal-full-title] Clinical cancer research : an official journal of the American Association for Cancer Research
  • [ISO-abbreviation] Clin. Cancer Res.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / 1 P20 CA101936; United States / NCI NIH HHS / CA / R21 CA104337
  • [Publication-type] Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Cytokines; 0 / NF-kappa B; EC 1.14.99.1 / Cyclooxygenase 2; IT942ZTH98 / Curcumin
  •  go-up   go-down


88. Jin J, Li YX, Wang JW, Wang WH, Liu YP, Wang K, Fang H, Zhou ZX, Zhou AP, Yu ZH: Phase I study of oxaliplatin in combination with capecitabine and radiotherapy as postoperative treatment for stage II and III rectal cancer. Int J Radiat Oncol Biol Phys; 2008 Nov 1;72(3):671-7
Hazardous Substances Data Bank. FLUOROURACIL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PATIENTS AND METHODS: A total of 21 patients with Stage II or III rectal adenocarcinoma after curative surgery were treated with radiotherapy to a total dose of 50 Gy in 5 weeks.
  • CONCLUSIONS: OXA combined with a fixed dose of capecitabine at 625 mg/m(2) twice daily by mouth plus radiotherapy in the adjuvant setting was tolerable and clinically feasible.

  • Genetic Alliance. consumer health - Rectal Cancer.
  • MedlinePlus Health Information. consumer health - Radiation Therapy.
  • Hazardous Substances Data Bank. CAPECITABINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18455328.001).
  • [ISSN] 1879-355X
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase I; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Organoplatinum Compounds; 0 / Pyridines; 0 / oxiplatin; 0W860991D6 / Deoxycytidine; 6804DJ8Z9U / Capecitabine; U3P01618RT / Fluorouracil
  •  go-up   go-down


89. Retnakumari A, Setua S, Menon D, Ravindran P, Muhammed H, Pradeep T, Nair S, Koyakutty M: Molecular-receptor-specific, non-toxic, near-infrared-emitting Au cluster-protein nanoconjugates for targeted cancer imaging. Nanotechnology; 2010 Feb 5;21(5):055103
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Molecular-receptor-targeted imaging of folate receptor positive oral carcinoma cells using folic-acid-conjugated fluorescent Au(25) nanoclusters (Au NCs) is reported.
  • Receptor-targeted cancer detection using Au clusters is demonstrated on FR(+ve) oral squamous cell carcinoma (KB) and breast adenocarcinoma cell MCF-7, where the FA-conjugated Au(25) clusters were found internalized in significantly higher concentrations compared to the negative control cell lines.
  • [MeSH-major] Carrier Proteins / metabolism. Folic Acid / chemistry. Gold / chemistry. Mouth Neoplasms / diagnosis. Nanocomposites / chemistry. Receptors, Cell Surface / metabolism

  • MedlinePlus Health Information. consumer health - Folic Acid.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • Hazardous Substances Data Bank. FOLIC ACID .
  • Hazardous Substances Data Bank. GOLD, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20023317.001).
  • [ISSN] 1361-6528
  • [Journal-full-title] Nanotechnology
  • [ISO-abbreviation] Nanotechnology
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Carrier Proteins; 0 / Folate Receptors, GPI-Anchored; 0 / Formazans; 0 / Reactive Oxygen Species; 0 / Receptors, Cell Surface; 0 / Serum Albumin, Bovine; 0 / Tetrazolium Salts; 23305-68-2 / MTT formazan; 7440-57-5 / Gold; 935E97BOY8 / Folic Acid
  •  go-up   go-down


90. Jeong HK, Park CH, Jun CH, Lee GH, Kim HI, Kim HS, Choi SK, Rew JS: A prospective randomized trial of either famotidine or pantoprazole for the prevention of bleeding after endoscopic submucosal dissection. J Korean Med Sci; 2007 Dec;22(6):1055-9
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In a prospective trial, patients undergoing ESD due to gastric adenoma or adenocarcinoma were randomly assigned to pantoprazole or famotidine.
  • Both drugs were given intravenously for the first 2 days, thereafter by mouth.

  • MedlinePlus Health Information. consumer health - Gastrointestinal Bleeding.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • Hazardous Substances Data Bank. PANTOPRAZOLE .
  • Hazardous Substances Data Bank. FAMOTIDINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] N Engl J Med. 2000 Aug 3;343(5):310-6 [10922420.001]
  • [Cites] Gastrointest Endosc. 2006 Dec;64(6):877-83 [17140890.001]
  • [Cites] Gastrointest Endosc. 2002 Mar;55(3):390-6 [11868015.001]
  • [Cites] Gastrointest Endosc. 2002 Apr;55(4):576-81 [11923778.001]
  • [Cites] Gastrointest Endosc. 2002 Oct;56(4):507-12 [12297765.001]
  • [Cites] Gastrointest Endosc. 2003 Apr;57(4):567-79 [12665775.001]
  • [Cites] Gastrointest Endosc. 2003 May;57(6):687-90 [12709698.001]
  • [Cites] Endoscopy. 2003 Jul;35(7):611-2 [12822098.001]
  • [Cites] Endoscopy. 2003 Aug;35(8):690-4 [12929067.001]
  • [Cites] Am J Gastroenterol. 2003 Dec;98(12):2635-41 [14687809.001]
  • [Cites] Endoscopy. 2004 Sep;36(9):788-801 [15326574.001]
  • [Cites] Endoscopy. 2004 Sep;36(9):808-10 [15326576.001]
  • [Cites] Gastroenterology. 1978 Jan;74(1):38-43 [21830.001]
  • [Cites] Scand J Gastroenterol Suppl. 1987;134:55-60 [2889260.001]
  • [Cites] Arch Intern Med. 1998 Jan 12;158(1):54-8 [9437379.001]
  • [Cites] Endoscopy. 1999 Jan;31(1):47-55 [10082409.001]
  • [Cites] Gastrointest Endosc. 1999 Aug;50(2):251-6 [10425422.001]
  • [Cites] Aliment Pharmacol Ther. 1999 Aug;13 Suppl 3:18-26 [10491725.001]
  • [Cites] Intern Med. 2004 Dec;43(12):1120-5 [15645644.001]
  • [Cites] Aliment Pharmacol Ther. 2005 Jun;21 Suppl 2:111-5 [15943857.001]
  • [Cites] Dig Dis Sci. 2006 Jan;51(1):123-31 [16416224.001]
  • [Cites] Gastrointest Endosc. 2006 Feb;63(2):243-9 [16427929.001]
  • [Cites] World J Gastroenterol. 2005 Dec 14;11(46):7335-9 [16437638.001]
  • [Cites] Aliment Pharmacol Ther. 2006 Sep 1;24(5):837-43 [16918888.001]
  • [Cites] Endoscopy. 2001 Mar;33(3):221-6 [11293753.001]
  • (PMID = 18162722.001).
  • [ISSN] 1011-8934
  • [Journal-full-title] Journal of Korean medical science
  • [ISO-abbreviation] J. Korean Med. Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Randomized Controlled Trial
  • [Publication-country] Korea (South)
  • [Chemical-registry-number] 0 / 2-Pyridinylmethylsulfinylbenzimidazoles; 0 / Anti-Ulcer Agents; 5QZO15J2Z8 / Famotidine; D8TST4O562 / pantoprazole
  • [Other-IDs] NLM/ PMC2694634
  •  go-up   go-down


91. Reimer TA, Anagnostopoulos I, Erdmann B, Lehmann I, Stein H, Daniel P, Dörken B, Rehm A: Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker. BMC Cancer; 2005;5:47
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adenocarcinoma / metabolism. Antibodies, Monoclonal / chemistry. Antibodies, Monoclonal / metabolism. Antigens, Tumor-Associated, Carbohydrate / chemistry. Antineoplastic Agents / pharmacology. Apoptosis. Brefeldin A / pharmacology. Carcinoma / metabolism. Carcinoma, Squamous Cell / metabolism. Caspase 3. Caspase 7. Caspases / biosynthesis. Cell Line. Cell Line, Tumor. Cell Nucleus / metabolism. Colorectal Neoplasms / metabolism. Flow Cytometry. Golgi Apparatus / metabolism. Humans. Immunoblotting. Immunohistochemistry. Immunotherapy / methods. Lung Neoplasms / metabolism. Male. Microscopy, Confocal. Microscopy, Electron. Mouth Neoplasms / metabolism. Nocodazole / pharmacology. Polysaccharides / chemistry. Prostatic Neoplasms / metabolism. Protein Synthesis Inhibitors / pharmacology. Reverse Transcriptase Polymerase Chain Reaction. Stomach Neoplasms / metabolism. Subcellular Fractions. Tissue Distribution

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Pathol Oncol Res. 1999;5(3):197-204 [10491017.001]
  • [Cites] Nat Med. 1999 Aug;5(8):938-42 [10426319.001]
  • [Cites] Biochem Biophys Res Commun. 2000 Jul 5;273(2):654-60 [10873660.001]
  • [Cites] Int J Cancer. 2000 Nov 20;89(6):488-93 [11102892.001]
  • [Cites] Biochem Biophys Res Commun. 2001 Jun 1;284(1):2-10 [11374862.001]
  • [Cites] Int J Oncol. 2001 Oct;19(4):695-700 [11562743.001]
  • [Cites] Biochem Biophys Res Commun. 2002 May 24;293(5):1544-9 [12054692.001]
  • [Cites] Cancer Cell. 2002 Feb;1(1):19-30 [12086884.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10231-3 [12149519.001]
  • [Cites] J Biol Chem. 2003 Jun 20;278(25):22998-3007 [12672804.001]
  • [Cites] Int J Cancer. 2003 Sep 1;106(3):310-5 [12845666.001]
  • [Cites] Eur J Cancer. 2003 Jul;39(11):1552-61 [12855262.001]
  • [Cites] Mod Pathol. 2003 Jul;16(7):679-85 [12861064.001]
  • [Cites] Nat Rev Immunol. 2003 Aug;3(8):630-41 [12974478.001]
  • [Cites] Cancer Sci. 2004 Mar;95(3):260-5 [15016327.001]
  • [Cites] Br J Cancer. 2004 Jun 1;90(11):2197-202 [15164121.001]
  • [Cites] J Cell Biol. 1984 Sep;99(3):1092-100 [6381504.001]
  • [Cites] J Microsc. 1986 Aug;143(Pt 2):139-49 [3531524.001]
  • [Cites] Cell. 1990 Mar 9;60(5):821-36 [2178778.001]
  • [Cites] Cell. 1991 Jul 26;66(2):233-43 [1713127.001]
  • [Cites] J Pathol. 1994 Aug;173(4):371-9 [7965396.001]
  • [Cites] Virchows Arch. 1995;427(3):251-8 [7496593.001]
  • [Cites] Cancer. 1996 Apr 15;77(8):1501-9 [8608535.001]
  • [Cites] Cancer Res. 1996 May 1;56(9):2229-32 [8616877.001]
  • [Cites] Yeast. 1996 Mar 30;12(4):333-48 [8701606.001]
  • [Cites] Virchows Arch. 1997 Sep;431(3):159-66 [9334836.001]
  • [Cites] Mol Biol Cell. 2005 Mar;16(3):1245-57 [15635093.001]
  • (PMID = 15904507.001).
  • [ISSN] 1471-2407
  • [Journal-full-title] BMC cancer
  • [ISO-abbreviation] BMC Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / 22-1-1 antigen; 0 / Antibodies, Monoclonal; 0 / Antigens, Neoplasm; 0 / Antigens, Tumor-Associated, Carbohydrate; 0 / Antineoplastic Agents; 0 / Biomarkers, Tumor; 0 / EBAG9 protein, human; 0 / Polysaccharides; 0 / Protein Synthesis Inhibitors; 0 / Tn antigen; 20350-15-6 / Brefeldin A; EC 3.4.22.- / CASP3 protein, human; EC 3.4.22.- / CASP7 protein, human; EC 3.4.22.- / Caspase 3; EC 3.4.22.- / Caspase 7; EC 3.4.22.- / Caspases; SH1WY3R615 / Nocodazole
  • [Other-IDs] NLM/ PMC1164403
  •  go-up   go-down


92. King M, Chatelain K, Farris D, Jensen D, Pickup J, Swapp A, O'Malley S, Kingsley K: Oral squamous cell carcinoma proliferative phenotype is modulated by proanthocyanidins: a potential prevention and treatment alternative for oral cancer. BMC Complement Altern Med; 2007;7:22
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Oral squamous cell carcinoma proliferative phenotype is modulated by proanthocyanidins: a potential prevention and treatment alternative for oral cancer.
  • BACKGROUND: Despite the recently reported drop in the overall death rate from cancer, the estimated survival rate and number of deaths from oral cancer remain virtually unchanged.
  • The primary purpose of this study was to investigate the response of human oral squamous cell carcinoma (OSCC) to proanthocyanidin (PAC), a plant-derived compound that may inhibit the progression of several other cancers.
  • Our results also provide preliminary evidence that PAC administration may induce apoptosis in cervical and oral cancer cell lines, while acting merely to suppress proliferation of the normal cell line control.
  • [MeSH-major] Carcinoma, Squamous Cell / drug therapy. Mouth Neoplasms / drug therapy. Proanthocyanidins / pharmacology
  • [MeSH-minor] Adenocarcinoma / drug therapy. Cell Line, Tumor. Cell Proliferation / drug effects. Dose-Response Relationship, Drug. Female. Fibroblasts / drug effects. Human papillomavirus 16. Humans. Papillomavirus Infections / drug therapy. Phenotype. Uterine Cervical Neoplasms / drug therapy

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • Genetic Alliance. consumer health - Oral cancer.
  • Genetic Alliance. consumer health - Oral squamous cell carcinoma.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Anticancer Res. 2000 Jan-Feb;20(1A):271-7 [10769666.001]
  • [Cites] J Dent Res. 2007 Feb;86(2):104-14 [17251508.001]
  • [Cites] Toxicology. 2000 Aug 7;148(2-3):187-97 [10962138.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10544-8 [10962037.001]
  • [Cites] J Agric Food Chem. 2000 Nov;48(11):5331-7 [11087482.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Jun;91(6):622-35 [11402272.001]
  • [Cites] Free Radic Res. 2001 Aug;35(2):181-94 [11697199.001]
  • [Cites] J Agric Food Chem. 2002 Feb 27;50(5):1063-9 [11853481.001]
  • [Cites] Biochem Biophys Res Commun. 2002 May 10;293(3):1000-6 [12051759.001]
  • [Cites] Ann N Y Acad Sci. 2002 May;957:260-70 [12074978.001]
  • [Cites] J Agric Food Chem. 2002 Aug 14;50(17):4852-60 [12166971.001]
  • [Cites] Biomed Pharmacother. 2002 Aug;56(6):296-301 [12224601.001]
  • [Cites] Cancer Metastasis Rev. 2002;21(3-4):231-55 [12549763.001]
  • [Cites] Oncogene. 2003 Mar 6;22(9):1302-16 [12618755.001]
  • [Cites] Mutat Res. 2003 Feb-Mar;523-524:87-97 [12628506.001]
  • [Cites] Biosci Biotechnol Biochem. 2003 May;67(5):1140-3 [12834296.001]
  • [Cites] Biochemistry (Mosc). 2004 Jan;69(1):75-80, 1 p preceding 75 [14972022.001]
  • [Cites] J Nutr. 2004 Mar;134(3):613-7 [14988456.001]
  • [Cites] Oral Oncol. 2004 May;40(5):461-73 [15006617.001]
  • [Cites] J Agric Food Chem. 2004 May 5;52(9):2512-7 [15113149.001]
  • [Cites] Carcinogenesis. 2004 Jun;25(6):987-95 [14742313.001]
  • [Cites] Thromb Res. 2005;115(1-2):115-21 [15567462.001]
  • [Cites] J Nutr. 2004 Dec;134(12 Suppl):3445S-3452S [15570052.001]
  • [Cites] Am J Clin Nutr. 2005 Jan;81(1 Suppl):230S-242S [15640486.001]
  • [Cites] Mol Cell Biochem. 2006 Jan;281(1-2):197-209 [16328973.001]
  • [Cites] J Nutr Biochem. 2006 Feb;17(2):117-25 [16111875.001]
  • [Cites] Chin Med J (Engl). 2006 Mar 5;119(5):417-21 [16542587.001]
  • [Cites] Endocr Metab Immune Disord Drug Targets. 2006 Mar;6(1):17-24 [16611161.001]
  • [Cites] Am J Clin Nutr. 2006 May;83(5):1126-34 [16685056.001]
  • [Cites] Cancer Res. 2006 Jun 1;66(11):5960-7 [16740737.001]
  • [Cites] Nutr Cancer. 2006;54(1):58-68 [16800773.001]
  • [Cites] Otolaryngol Head Neck Surg. 2006 Sep;135(3):451-7 [16949981.001]
  • [Cites] Biofactors. 2006;27(1-4):245-65 [17012779.001]
  • [Cites] Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6194-202 [17062697.001]
  • [Cites] J Nutr. 2007 Jan;137(1 Suppl):186S-193S [17182824.001]
  • [Cites] Anticancer Res. 2000 Jan-Feb;20(1A):423-6 [10769690.001]
  • (PMID = 17578576.001).
  • [ISSN] 1472-6882
  • [Journal-full-title] BMC complementary and alternative medicine
  • [ISO-abbreviation] BMC Complement Altern Med
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Proanthocyanidins
  • [Other-IDs] NLM/ PMC1914364
  •  go-up   go-down


93. Bhutani M, Pathak AK, Fan YH, Liu DD, Lee JJ, Tang H, Kurie JM, Morice RC, Kim ES, Hong WK, Mao L: Oral epithelium as a surrogate tissue for assessing smoking-induced molecular alterations in the lungs. Cancer Prev Res (Phila); 2008 Jun;1(1):39-44
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Oral epithelium as a surrogate tissue for assessing smoking-induced molecular alterations in the lungs.
  • The lungs and oral cavity of smokers are exposed to tobacco carcinogens.
  • We hypothesized that tobacco-induced molecular alterations in the oral epithelium are similar to those in the lungs, and thus the oral epithelium may be used as a surrogate tissue for assessing alterations in the lungs.
  • We used methylation-specific PCR to analyze promoter methylation of the p16 and FHIT genes at baseline and 3 months after intervention in 1,774 oral and bronchial brush specimens from 127 smokers enrolled in a randomized placebo-controlled chemoprevention trial.
  • The association between methylation patterns in oral tissues and bronchial methylation indices (methylated sites / total sites per subject) was analyzed in a blinded fashion.
  • At baseline, promoter methylation in bronchial tissue was present in 23% of samples for p16, 17% for FHIT, and 35% for p16 and FHIT; these percentages were comparable to methylation in oral tissue: 19% (p16), 15% (FHIT), and 31% (p16 and FHIT).
  • Data from both oral and bronchial tissues were available for 125 individuals, in whom the two sites correlated strongly with respect to alterations (P < 0.0001 for both p16 and FHIT).
  • At baseline, the mean bronchial methylation index was far higher in patients with oral tissue methylation (in either of the two genes; 39 patients) than in patients without oral tissue methylation (86 patients): 0.53 +/- 0.29 versus 0.27 + 0.26 methylation index (P < 0.0001).
  • Our results support the potential of oral epithelium as a surrogate tissue for assessing tobacco-induced molecular damage in the lungs and thus have important implications for designing future lung cancer prevention trials and for research into the risk and early detection of lung cancer.

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Smoking.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Cancer Prev Res (Phila). 2008 Jun;1(1):12-4 [19138931.001]
  • (PMID = 19138934.001).
  • [ISSN] 1940-6215
  • [Journal-full-title] Cancer prevention research (Philadelphia, Pa.)
  • [ISO-abbreviation] Cancer Prev Res (Phila)
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / P01 CA091844; United States / NCI NIH HHS / CA / P30 CA016672; United States / NCI NIH HHS / CA / CA-16672; United States / NCI NIH HHS / CA / CA091844
  • [Publication-type] Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers; 0 / Neoplasm Proteins; 0 / fragile histidine triad protein; EC 3.6.- / Acid Anhydride Hydrolases
  • [Other-IDs] NLM/ NIHMS630678; NLM/ PMC4183362
  •  go-up   go-down


94. Han S, Chen Y, Ge X, Zhang M, Wang J, Zhao Q, He J, Wang Z: Epidemiology and cost analysis for patients with oral cancer in a university hospital in China. BMC Public Health; 2010;10:196
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Epidemiology and cost analysis for patients with oral cancer in a university hospital in China.
  • BACKGROUND: Although several studies have reported the direct cost of oral cancer (OC), little research has invested the factors that could influence the costs of OC patient.
  • METHODS: All patients encountered from January 2007 to December 2007 at the School of Stomatology of the Fourth Military Medical University (FMMU) in China with diagnosis of oral cancer have been selected.
  • RESULTS: A total of 456 oral cancer patients have been selected in this study.
  • The epidemical characteristics are as follows: female/male 176/280; squamous cell carcinoma (SCC)/adenocarcinoma/sarcoma/lymphoma/other types 246/127/40/27/16; stage I/II/III/IV 90/148/103/115; smoker/non-smoker 136/320; rural/urban patients 82/374.
  • 372 of the patients received treatment and 84 gave up any treatment after diagnosis.
  • CONCLUSION: Gender, smoking habit and age older than 40 years are the epidemiological risk factors for oral cancer.
  • [MeSH-major] Hospital Costs / statistics & numerical data. Hospitalization / economics. Hospitals, University / economics. Mouth Neoplasms / economics. Mouth Neoplasms / epidemiology

  • Genetic Alliance. consumer health - Oral cancer.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Oral Maxillofac Surg. 2003 Jul;61(7):751-8 [12856245.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2003 Feb;129(2):219-28 [12578453.001]
  • [Cites] J Am Dent Assoc. 1972 Sep;85(3):637-40 [4505593.001]
  • [Cites] N Engl J Med. 1982 May 13;306(19):1151-5 [7040958.001]
  • [Cites] Oper Dent. 1989 Summer;14(3):114-20 [2637996.001]
  • [Cites] J Clin Anesth. 1994 Sep-Oct;6(5):357-63 [7986506.001]
  • [Cites] J Clin Oncol. 1998 Feb;16(2):745-53 [9469366.001]
  • [Cites] J Natl Cancer Inst. 1998 Nov 4;90(21):1626-36 [9811312.001]
  • [Cites] Support Care Cancer. 2005 Jan;13(1):32-41 [15549427.001]
  • [Cites] Oncologist. 2006 Jun;11(6):590-601 [16794238.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Jul;102(1):67-76 [16831675.001]
  • [Cites] Mayo Clin Proc. 2007 Jul;82(7):878-87 [17605971.001]
  • [Cites] Head Neck. 2008 Feb;30(2):178-86 [17694558.001]
  • [Cites] Curr Opin Otolaryngol Head Neck Surg. 2008 Apr;16(2):113-6 [18327029.001]
  • [Cites] J Can Dent Assoc. 2008 Apr;74(3):269-72 [18387267.001]
  • [Cites] J Can Dent Assoc. 2008 Apr;74(3):245 [18401902.001]
  • [Cites] Oral Dis. 2008 May;14(4):314-9 [18449960.001]
  • [Cites] J Oral Maxillofac Surg. 2008 Aug;66(8):1570-9 [18634942.001]
  • [Cites] Stomatologiia (Mosk). 2008;87(6):21-3 [19156101.001]
  • [Cites] Oral Oncol. 2009 Nov;45(11):958-62 [19502101.001]
  • [Cites] Br Dent J. 2000 Mar 11;188(5):262-5 [10758688.001]
  • [Cites] J Dent Educ. 2001 Apr;65(4):328-39 [11336118.001]
  • [Cites] Med Pediatr Oncol. 2002 Sep;39(3):149-55 [12210442.001]
  • [Cites] BMC Public Health. 2002 Jul 19;2:12 [12133170.001]
  • [Cites] J Can Dent Assoc. 2004 May;70(5):302-4 [15132812.001]
  • (PMID = 20398380.001).
  • [ISSN] 1471-2458
  • [Journal-full-title] BMC public health
  • [ISO-abbreviation] BMC Public Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2864212
  •  go-up   go-down


95. Zarovnaya E, Black C: Distinguishing pseudoepitheliomatous hyperplasia from squamous cell carcinoma in mucosal biopsy specimens from the head and neck. Arch Pathol Lab Med; 2005 Aug;129(8):1032-6
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To distinguish pseudoepitheliomatous hyperplasia from invasive squamous cell carcinoma, utilizing a panel of antibodies to various epithelial and stromal elements (p53, matrix metalloproteinase 1, E-cadherin, and collagen IV) that has been shown to be useful in differentiating intestinal adenomas with invasive adenocarcinoma from displaced adenomatous epithelium.
  • [MeSH-major] Carcinoma, Squamous Cell / diagnosis. Granular Cell Tumor / diagnosis. Head and Neck Neoplasms / diagnosis. Mouth Mucosa / pathology. Skin Diseases / diagnosis
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Biomarkers, Tumor / metabolism. Biopsy. Cadherins / metabolism. Child. Diagnosis, Differential. Female. Humans. Hyperplasia / pathology. Immunoenzyme Techniques. Male. Matrix Metalloproteinase 1 / metabolism. Middle Aged. Tumor Suppressor Protein p53 / metabolism


96. Faivre S, Delbaldo C, Vera K, Robert C, Lozahic S, Lassau N, Bello C, Deprimo S, Brega N, Massimini G, Armand JP, Scigalla P, Raymond E: Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer. J Clin Oncol; 2006 Jan 1;24(1):25-35
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer.
  • PURPOSE: To establish the safety, pharmacokinetics, and recommended dose of sunitinib, a novel oral multitargeting tyrosine kinase inhibitor with antiangiogenic and antitumor properties, in patients with advanced malignancies.
  • At this dose, the main adverse effects were sore mouth, edema, and thrombocytopenia.
  • Six objective responses were observed in three renal cell carcinomas, one neuroendocrine tumor, one stromal tumor, and one unknown primary adenocarcinoma patient.


97. Brønden LB, Eriksen T, Kristensen AT: Oral malignant melanomas and other head and neck neoplasms in Danish dogs--data from the Danish Veterinary Cancer Registry. Acta Vet Scand; 2009;51:54
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Oral malignant melanomas and other head and neck neoplasms in Danish dogs--data from the Danish Veterinary Cancer Registry.
  • In humans oral malignant melanoma (OMM) is extremely rare, but represents a particular challenge since it is highly aggressive as is the canine counterpart, which thus may be of interest as a spontaneous animal model.
  • The most common types of malignant neoplasia were SCC (18; 28% of malignant), OMM (13; 20% of malignant), soft tissue sarcoma (11; 17% of malignant) and adenocarcinoma (5; 11% of malignant).
  • [MeSH-major] Dog Diseases / epidemiology. Head and Neck Neoplasms / veterinary. Melanoma / veterinary. Mouth Neoplasms / veterinary. Registries

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Vet Pathol. 2000 Nov;37(6):597-608 [11105949.001]
  • [Cites] Vet Comp Oncol. 2009 Sep;7(3):207-11 [19691649.001]
  • [Cites] Lancet Oncol. 2001 Apr;2(4):205-11 [11905765.001]
  • [Cites] Prev Vet Med. 2003 Apr 30;58(1-2):63-74 [12628771.001]
  • [Cites] Clin Cancer Res. 2003 Apr;9(4):1284-90 [12684396.001]
  • [Cites] J Oral Maxillofac Surg. 2003 Oct;61(10):1132-9 [14586846.001]
  • [Cites] J Natl Cancer Inst. 1968 Feb;40(2):307-18 [5694272.001]
  • [Cites] Arch Environ Health. 1971 Jan;22(1):136-40 [4322006.001]
  • [Cites] Eur J Cancer. 1978 Dec;14(12):1299-308 [367792.001]
  • [Cites] Vet Hum Toxicol. 1979 Aug;21(4):277-84 [91256.001]
  • [Cites] Am J Epidemiol. 1981 Aug;114(2):229-33 [7304557.001]
  • [Cites] Onderstepoort J Vet Res. 1983 Sep;50(3):199-220 [6646663.001]
  • [Cites] Vet Rec. 1984 Apr 7;114(14):341-2 [6719788.001]
  • [Cites] Acta Vet Scand Suppl. 1988;84:290-2 [3232625.001]
  • [Cites] J Toxicol Environ Health. 1989;28(4):407-14 [2593174.001]
  • [Cites] Cancer Metastasis Rev. 1990 Sep;9(2):125-36 [2253312.001]
  • [Cites] Am J Epidemiol. 1992 Feb 1;135(3):234-9 [1546698.001]
  • [Cites] Zentralbl Veterinarmed A. 1992 Jun;39(5):328-41 [1496862.001]
  • [Cites] Tidsskr Nor Laegeforen. 1995 Feb 28;115(6):714-7 [7900133.001]
  • [Cites] Berl Munch Tierarztl Wochenschr. 1996 Aug;109(8):292-303 [9005839.001]
  • [Cites] Vet Clin North Am Small Anim Pract. 1997 Jan;27(1):101-13 [9002170.001]
  • [Cites] Mol Med Today. 1997 Jan;3(1):8-11 [9021736.001]
  • [Cites] Vet Rec. 1997 Jul 12;141(2):40-4 [9253830.001]
  • [Cites] Am J Epidemiol. 1998 Mar 1;147(5):488-92 [9525536.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1998 Sep;124(9):951-62 [9738803.001]
  • [Cites] Int J Cancer. 2005 May 1;114(5):806-16 [15609302.001]
  • [Cites] Vaccine. 2006 May 22;24(21):4582-5 [16188351.001]
  • [Cites] Oral Oncol. 2007 Feb;43(2):116-21 [16931116.001]
  • [Cites] Alcohol Res Health. 2006;29(3):193-8 [17373408.001]
  • [Cites] Clin Tech Small Anim Pract. 2007 May;22(2):55-60 [17591290.001]
  • [Cites] Vet Clin North Am Small Anim Pract. 2007 Nov;37(6):1111-9; vi-ii [17950885.001]
  • [Cites] Can Vet J. 2008 Jan;49(1):71-6 [18320982.001]
  • [Cites] Can Vet J. 2008 May;49(5):509-12 [18512465.001]
  • [Cites] Eur J Cancer Prev. 2008 Aug;17(4):340-4 [18562959.001]
  • [Cites] J Vet Intern Med. 2008 Jul-Aug;22(4):976-84 [18564221.001]
  • [Cites] Head Neck. 2008 Dec;30(12):1543-51 [18704960.001]
  • [Cites] Clin Cancer Res. 2009 Feb 15;15(4):1443-51 [19228745.001]
  • [Cites] Oral Oncol. 2009 Mar;45(3):254-8 [18675580.001]
  • [Cites] Cancer Invest. 2000;18(8):781-92 [11107448.001]
  • (PMID = 20021647.001).
  • [ISSN] 1751-0147
  • [Journal-full-title] Acta veterinaria Scandinavica
  • [ISO-abbreviation] Acta Vet. Scand.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2803174
  •  go-up   go-down


98. Ntoumazios SK, Voulgari PV, Potsis K, Koutis E, Tsifetaki N, Assimakopoulos DA: Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem. Semin Arthritis Rheum; 2006 Dec;36(3):173-81
MedlinePlus Health Information. consumer health - Scleroderma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Common esophageal manifestations in SSc include motility abnormalities and gastroesophageal reflux (GER), Barrett's esophagus, adenocarcinoma, infectious esophagitis, and drug-induced esophagitis.
  • Extraesophageal manifestations of GER include mouth ulcers, chronic cough, hoarse voice, sore throat, pharyngitis, laryngospasm, asthma, and recurrent pneumonia.

  • Genetic Alliance. consumer health - Gastroesophageal Reflux.
  • Genetic Alliance. consumer health - Scleroderma.
  • MedlinePlus Health Information. consumer health - GERD.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17045629.001).
  • [ISSN] 0049-0172
  • [Journal-full-title] Seminars in arthritis and rheumatism
  • [ISO-abbreviation] Semin. Arthritis Rheum.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 111
  •  go-up   go-down


99. Jarrosson C, Laure B, Bakhos D, Brygo A, Sury F, Goga D: [Oral metastasis of colonic adenocarcinoma]. Rev Stomatol Chir Maxillofac; 2005 Jun;106(3):182-3
MedlinePlus Health Information. consumer health - Oral Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Oral metastasis of colonic adenocarcinoma].
  • [MeSH-major] Adenocarcinoma, Mucinous / secondary. Colonic Neoplasms / pathology. Mouth Neoplasms / secondary

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15976708.001).
  • [ISSN] 0035-1768
  • [Journal-full-title] Revue de stomatologie et de chirurgie maxillo-faciale
  • [ISO-abbreviation] Rev Stomatol Chir Maxillofac
  • [Language] fre
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] France
  •  go-up   go-down


100. Rawal YB, Blakenship JA, Mincer HH, Parrish ML, Anderson KM: Metastatic adenocarcinoma of the breast presenting as pulpal/periodontal disease. J Tenn Dent Assoc; 2007;87(2):11-3; quiz 14-5
MedlinePlus Health Information. consumer health - Oral Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastatic adenocarcinoma of the breast presenting as pulpal/periodontal disease.
  • [MeSH-major] Breast Neoplasms / radiography. Carcinoma, Lobular / secondary. Mouth Neoplasms / secondary

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17539226.001).
  • [ISSN] 0040-3385
  • [Journal-full-title] The Journal of the Tennessee Dental Association
  • [ISO-abbreviation] J Tenn Dent Assoc
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down






Advertisement